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Abstract 
Background: Febrile neutropenia (FN) is among the most common side effects related to 
cancer treatment and a significant cause of morbidity and mortality. Patients with FN are 
at a higher risk of developing life-threatening sepsis without prompt treatment.  
Purpose: To evaluate the quality of emergency care of cancer patients with FN. 
Specifically, the study aimed to examine the effectiveness of triage on select treatment 
outcomes for patients with FN as specified by the Canadian triage guidelines.  
Methods: A retrospective cohort design was employed to collect data over five years from 
the emergency department (ED) records of all adult cancer patients with FN in one urban 
health care organization in Atlantic Canada. 
Results: The Canadian triage guidelines identify the acuity and urgency of FN. The 
guidelines, however, do not translate well in practice as two-thirds of the patient sample 
were inappropriately triaged (mal-triaged) to less urgent triage categories. Mal-triage was 
significantly associated with delayed times for physician initial assessment, 
administration of antibiotics, and decision about admission. Additional factors that 
contributed to the quality of ED care of cancer patients with FN were also examined.  
Conclusion: The results of our quality evaluation provided evidence that improvements in 
a number of the quality dimensions have the potential to enhance the care provided to 
individuals with FN. Our results established an initial understanding of the factors that 
influence the mal-triage of patients with FN. Improving triage decision-making is an 
essential first step but this will not completely improve the quality of care in the ED for 
clients presenting with FN until problems in other parts of the system are resolved to 
address the health care outcomes and needs of this vulnerable population. 
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 Chapter 1 
One of the complexities of emergency care is that the demand for service is 
unpredictable, and therefore, crowding within the emergency department (ED) is 
considered an inevitable event (Forero, Mccarthy, & Hillman, 2011). However, timely 
and effective care in a hospital ED is needed for good patient outcomes (Pines & 
Hollander, 2008). To achieve this objective, and despite the limited available resources, 
many EDs have established mechanisms to sort and prioritize patients to make sure that 
patients with life-threatening or medically urgent conditions are seen immediately while 
others with more stable conditions are seen later (Beveridge et al., 1998). Historically, 
EDs did not use standardized triage acuity rating systems, but since 1999, scales have 
been introduced to Canadian EDs to standardize triage decisions to be more objective and 
justified (Beveridge et al., 1998; Murray, Bullard, & Grafstein, 2004). Currently, different 
EDs worldwide use different triage scales, such as the Emergency Severity Index (ESI) 
developed in the United States, the Manchester Triage System in Britain, the Canadian 
Triage and Acuity Scale (CTAS) and, more recently, the Italian Triage Emergency 
Method. However, the recommendations from recent research support the adoption of 
more reliable and valid five-level triage scales including ESI or CTAS (Ruiperez et al., 
2015).  
The CTAS categorizes ED arrival acuity into one of five numeric levels based on 
how urgently, in terms of minutes, patients need to be seen by the ED physician. These 
categories are: level 1, resuscitation (immediate lifesaving treatment by both nurse and 
physician); level 2, emergent (up to 15 minutes to be seen by a physician and nurse); level 
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3, urgent (to be seen by a physician in less than 30 minutes); level 4, less-urgent (to be 
seen by a physician within 60 minutes); and level 5, non-urgent (up to 120 minutes to be 
seen by a physician) (Beveridge et al., 1998). The ESI facilitates prioritization of patients 
in a comparable way to the CTAS. In addition to determining which patient should be 
seen first, the triage nurse uses the ESI to consider what resources are necessary to move 
the patient to the final, appropriate disposition (admission, discharge, or transfer) (Martin 
et al., 2014; Shelton, 2009). 
The primary objective for instituting these triage scales was a need for guidelines 
that would support ED nurses in the correct identification of patients’ conditions, and 
therefore ensure appropriate emergency care is provided promptly (Beveridge et al., 
1998). However, previous research in the area of ED triage has raised concerns about the 
effectiveness and the safety of ED triage, noting that patients’ outcomes may be 
compromised, particularly the outcomes of cancer patients (Leak et al., 2012; Oatley, Fry, 
& Mullen., 2016; Swenson et al., 1995). The developers of the CTAS recommended 
health care organization to continuously monitor to verify that the time objectives in the 
guidelines are met, and to assess the consistency of the triage process and the compliance 
in following the guidelines (Bullard, Unger, Spence, & Grafstein, 2008). 
According to the CTAS guidelines, time objectives are designed to promote the 
timely delivery of interventions that would result in improved patient outcomes 
(Beveridge et al., 1998). However, from the limited available research investigating ED 
care of cancer patients, the results showed that many patients did not reach the 
benchmarked time for treatment even if they presented with an urgent oncological 
emergency such as febrile neutropenia (FN) (Nirenberg, Mulhearn, Lin, & Larson, 2004; 
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Oatley et al., 2016; Swenson et al., 1995; Szwajcer, Czaykowski, & Turner., 2011). There 
is a considerable gap in the literature for interventions to improve the care of oncology 
patients in the ED. Studies are lacking that determine the appropriateness of the triage 
implementation and assess the effectiveness of triage in improving patient outcomes. In 
particular, research is needed to evaluate the impact of triage on patients with FN and to 
examine if delayed treatment can be attributed to their triage rating.  
The purpose of this thesis was to evaluate the quality of ED care of cancer patients 
with FN. Specifically, to examine the effectiveness of the triage process in facilitating 
patient care as specified by the CTAS guidelines. In this first chapter of the thesis, I 
provide a general overview of available literature for evidence about the effectiveness of 
the triage system in facilitating patients’ care in the emergency setting. I highlight issues 
regarding consistency and accuracy in the implementation of emergency triage. I review 
the health burdens associated with FN regarding morbidities and mortalities. I question 
the effectiveness of triage in improving the treatment outcomes of patients with FN, 
documenting research studies that report on multiple adverse outcomes among patients 
with FN. I formulate a hypothesis attributing these adverse outcomes to the delayed 
emergency care and/or the triage decisions that were made.  
My thesis consists of three manuscripts with the first manuscript presented in 
Chapter 2. In this manuscript, I report on a thorough review of the literature that was 
conducted to examine the urgency of oncological complaints and emergencies with an 
evaluation of the CTAS guidelines in identifying these urgencies. The literature on 
oncological emergencies is discussed as it relates to the nature and urgency of these 
oncological complaints with a focus on FN as the most common oncological emergency. I 
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examined the literature as it relates to the electronic triage that is commonly used in 
Canadian triage EDs. To conduct this analysis, I applied the CTAS guidelines using the 
2012 complaint-oriented triage (COT) in a simulated triage of select oncological 
emergencies, and examined if their urgency could be prioritized appropriately using the 
CTAS guidelines. 
In Chapter 3 and Chapter 4, which constitute the second and third manuscripts 
respectively, I report and discuss the results obtained from analyzing the data that were 
collected from patients’ medical records in our retrospective cohort study. Chapter 3 is 
focused on evaluating the quality of ED care in the form of an analysis of CTAS 
benchmarks relative to cancer patients presenting to ED with FN. The aim was to 
evaluate the ED quality of care for patients with FN in terms of the four quality 
dimensions: safety, effectiveness, patient-centeredness, and timeliness of care. I also 
assessed if the patients whose medical records were included in the study met the 
benchmark times for treatment as specified in the Canadian Triage and FN guidelines.  
Chapter 4 is dedicated to studying the effect of ED triage on the treatment 
outcomes of patients with FN. The purpose was to evaluate whether cancer patients 
received the appropriate triage score when they presented with FN and to explore the 
effect of mal-triage (inappropriate triage) on their treatment outcomes. Therefore, the 
effectiveness of the triage system was evaluated to understand the health risks associated 
with delayed emergency care. This study is a type of clinical quality audit that can inform 
prospective adoption of rational policies and guide a real change to enhance the efficiency 
and effectiveness of ED processes in the direction of positive patient outcomes. In 
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Chapter 5, the findings and implications of the findings included in this thesis are 
summarized, discussed, and placed in broader perspective.   
Research Questions 
The thesis was guided by four research questions and are addressed in different 
manuscripts. The first research question is discussed in the second chapter (first 
manuscript) and is concerned with the conceptualization of the triage guidelines at the 
theoretical level. In this chapter, we examine if the acuity of the oncological emergencies 
including FN was identified in the CTAS guidelines. The second research question 
guided the study of ED quality of care and is discussed in Chapter 3 (second manuscript). 
The third and fourth research questions guided the study discussed in Chapter 4 (third 
manuscript) and are concerned with the effectiveness of triage implementation in practice. 
1. Do the Canadian Emergency Department Triage and Acuity Scale (CTAS) guidelines 
identify the urgency of select oncological emergencies? 
2. What is the quality of ED care of patients with FN in terms of the four quality 
dimensions: safety, effectiveness, patient-centeredness, and timeliness of care? 
3. What effect does the mal-triage of patients with FN have on meeting care standards 
(time for the physician initial assessment and time to antibiotics), the decision time to 
admit/discharge, and length of stay (LOS)? 
4. Can contextual factors (arrival time, arrival day, mode of arrival, and ED crowding) 
and select patient characteristics (age, sex, and vital signs) predict the occurrence of 
mal-triage among patients with FN? 
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The Significance of the Study 
The majority of studies evaluating ED triage using CTAS were done to assess the 
reproducibility of the decision between triage nurses (inter-rater reliability). However, an 
interesting question is whether triage decisions were made correctly (i.e., the validity and 
accuracy of triage decisions). All raters can agree with one another and still be wrong. 
Many studies illustrated the lack of consistency among nurses in making triage decisions 
with the majority of patients being incorrectly triaged. However, a better question is one 
that examine the impact of accurate triage on patient outcomes. No studies have been 
located to date that explored the effect of ED triage on outcomes for cancer patients.  
Evaluating triage implementation for patients with an oncological emergency such 
as FN could improve the care provided in the ED, expand the knowledge base of 
emergency care, and identify areas where changes are needed. This study can identify any 
gap in timing that might exist between what should be achieved as stated by CTAS 
guidelines and what was actually accomplished. The study findings may inform 
clinicians, administrators, researchers, and policymakers about the performance of the 
triage system and its effectiveness in promoting positive patient outcomes.  
Conceptual Model 
The commitment to base our actions on evidence is one of the most significant 
advances in health care in the twentieth century (Grol et al., 2013). The effectiveness of 
care assumes that the right care (not overuse, underuse, or misuse) is delivered to the 
patient (Berwick, 2014). Health decisions or interventions are supposed to be based on 
the best available evidence that was found to have efficacy on health outcomes (Polit & 
Beck, 2010). It is of importance to be pragmatic and follow the principles of scientific 
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approach in our nursing practice (Polit & Beck, 2010). It allows clinicians to choose the 
treatment that has known efficacy and adapt them using their critical reasoning and 
experience as well as patient preferences (Romyn et al., 2003). To be pragmatic, 
something is real only insofar as it works and has practical consequences. Accordingly, it 
is crucial to examine the implementation of the triage guidelines in the practice (Issaacs, 
Ploeg, & Tompkins, 2009). Within this framework, care processes are performed to 
improve patient outcomes. One of the well-supported models that can explain this 
relationship between the care that is delivered and patient outcomes is the Donabedian 
Model. The model categorizes quality of care as measured indicators in the form of 
structure, process, and outcome variables. Structure variables are mainly concerned with 
the available relevant resources for the treatment process, which can be easily measured 
but are often difficult to link directly to the quality of care such as available bed capacity. 
Process variables reflect what is done for the patient and include actions and interventions 
aimed at both identifying and resolving the problem and are usually derived from 
evidence-based guidelines. Outcome indicators measure the effect of treatment and the 
degree to which patient health is restored (Kelly, Vottero, Christie-McAuliffe, Morita, & 
Altmiller, 2014).  
Therefore, if the right care is provided to patients, there would be a higher 
probability of achieving positive health outcomes. However, some discrepancies in the 
provision of health care in the form of overuse (e.g., overdose or aggressive therapy), 
underuse (e.g., smaller dose), or misuse (e.g., unnecessary or wrong treatment) can be 
associated with adverse outcomes. Unfortunately, multiple reports suggest that in many 
incidences, the second scenario is the dominant practice in our health care system 
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
 
8 
(Berwick, 2014; Graham & Varghese, 2011; Grol et al., 2013; Kelly et al., 2014). Despite 
the vast evidence of effective treatment, healthcare workers tend to provide alternative 
care that is not based on evidence and in contrast with the current evidence (Davey, 
2015). 
In the context of triage, the structural indicators such as the CTAS guidelines or 
the Complaint Oriented Triage (COT) (an interactive computerized CTAS triage tool) are 
instituted to help triage decision making. The application of the CTAS guidelines is 
mandatory in Canada and thought to enhance objective triage decision-making so that, for 
example, the benchmark for all individuals with FN is that they are seen by the ED 
physician within 15 minutes. The objective of using the triage guidelines is to promote 
patient outcomes in ED. If a triage nurse accurately assigns a CTAS score of 2 to the 
patient with FN, the patient will be enabled to meet the FN guidelines recommended 
benchmark time for treatment. Therefore, following the recommended care of the 
guidelines can be considered the best practice as such care was found to be associated 
with better patient outcomes (Bullard et al., 2017; Freifeld et al., 2011).  
According to the Donabedian Model, the assigned triage score can be considered a 
process indicator that helps determine the treatment outcomes of patients with FN in the 
ED. These treatment outcomes for my studies are represented by the different ED 
processes that have been found to be an essential determinant of health outcomes for 
patients with FN (Bullard et al., 2017; Freifeld et al., 2011; Keng et al., 2015; Rosa & 
Goldani, 2014; Morneau et al., 2017). These quality indicators included measures 
regarding safety, effectiveness, patient-centeredness, and timeliness of care to include but 
were not limited to i) time for the physician initial assessment (PIA), ii) time to antibiotics 
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(TTA), iii) the decision time to admit/discharge, iv) ED length of stay (ED LOS), v) ED 
disposition, and vi) hospital length of stay (hospital LOS). Since the associations between 
these treatment outcomes and patient health outcomes are well supported in the literature, 
our study is mainly focused on structural and process indicators rather health outcomes. 
Figure 1 depicts the expected relationships between the measured quality indicators.  
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Figure 1 
Conceptual Model of the Expected Relationship between Quality Indicators  
Note. Each of the manuscript of the thesis was concerned certain part of the model. For example, 
the first manuscript was focused on the structural indicator of the COT (Complaint Oriented 
Triage). The second and third manuscript evaluated the process indicators. Also, not all variables 
depicted in the figure were studied in the thesis. The following variables were not part of my 
study: e-CTAS, time to labs, consultation, patient experience, sepsis, septic shock, and mortality. 
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Methods 
A retrospective cohort design was used to collect data from all available records 
of adult patients diagnosed with cancer who presented with fever to one urban ED triage 
in Atlantic Canada. Data were collected by conducting chart reviews using a 
standardized, piloted, chart review form (CRF) (Appendix A). A pilot test of the CRF was 
performed, and changes were made as necessary to enhance the rigor and minimize 
biases. Each patient was assigned a unique, de-identified study code to protect the 
confidentiality of their information. The de-identified data will be kept for five years in a 
locked office & locked cabinet within the graduate office of the school of nursing in the 
education building (ED-5004). 
Identification of relevant health records required data linkages between the 
provincial cancer registry and ED electronic patient health records. The Cancer Registry 
identified all adults who received a cancer diagnosis between 2011/12 and 2016/17. This 
list of individuals was sent by the Cancer Registry to a provincial health information 
agency to conduct the data linkage. The health information agency identified all target 
patients from the Cancer Registry using the following inclusion criteria: i) diagnosed with 
cancer, ii) 18 years and older, iii) presented with fever to the ED during the study period, 
iv) the date of ED presentation was later than the date of cancer diagnosis, and v) only the 
first ED visit for fever was included. All data transfer occurred securely through the 
Managed File Transfer (MFT) system.  
Power Analysis 
To enable sample size calculation using the t-test sample size equation, the five-
ordinal level of CTAS score (predictor variable) will be dichotomized into low acuity 
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
 
12 
triage (III, IV, & V) and high acuity triage (I or II). In theory, patients with FN are 
assigned to a CTAS score of 2 and expected to wait for up to 15 minutes. However, in 
reality, the median wait times for patients presenting to ED with FN was 75 minutes 
(Szwajcer et al., 2011). Similarly, those patients are expected to start empiric antibiotics 
administration within an hour of their presentation (60 minutes). Despite the guidelines, 
the median time to antibiotic administration was between 3- 5 hours (180-300 minutes). If 
we assume that patients with correct triage score (CTAS2) were enabled to meet the TTA 
benchmark (60 minutes) and that patients who were mal-triaged (CTAS 3, CTAS 4, & 
CTAS 5) achieved the observed TTA (180-300 minutes), the estimated effect size range 
can be calculated as the difference in the value of the observed against the expected TTA 
between the exposed versus unexposed group (E=300-60=240; E=180-60=120; 
E[range]:120-240). In order to use the t-test sample size equation for the binary predictor 
variable (exposed vs unexposed) and continuous outcome variables of time (e.g., TTA) 
we need the variance of time from door to needle which can be estimated from a previous 
study of patients with FN where time range from ED triage to TTA was 1.23–22.8 hours 
(SD= [22.8-1.23]/4*60=324 minutes) (Szwajcer et al., 2011). Therefore, the standardized 
effect size range (E/S) can now be calculated by dividing the effect size by the standard 
deviation of the outcome variable (TTA) (E/S=120/324=0.37≈ 0.40; 
E/S=240/324=0.74≈0.70). At a two-sided hypothesis (α=0.05) and b=0.20 assuming a 
standardized effect size of 0.40, it would require a sample size of 100 or more participants 
in each group (n=200). At a two-sided hypothesis (α=0.05) and b=0.20 assuming a 
standardized effect size of 0.70, it would require a sample size of 34 or more participants 
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in each group (n=68). If we estimate the attrition rate at 30% due to mission information, 
it would be required an additional 60 participants (Hulley et al., 2013).  
Literature Review 
The review of literature includes a synthesis of available research articles in the 
domain of emergency care and ED triage as well as articles reporting on the assessment 
and management of oncological complaints and emergencies. An electronic search of 
EBSCOhost CINAHL and the MEDLINE databases was used to identify all relevant 
scientific articles published up-to-date (February 2019). To complete the search, Google 
and Google Scholar search engines were used to undertake a broader search of the World 
Wide Web. We reviewed all articles with the key terms Emergency Severity Index (ESI), 
Canadian Triage Acuity Scale (CTAS), ED triage, ED wait times, oncological complaints 
and emergencies, febrile neutropenia, neutropenic fever, and patient outcomes from both 
qualitative and quantitative methods. A limited number of published studies were 
identified that evaluated the emergency care of cancer patients; however, none of these 
studies examined the effect of ED triage or wait times on the outcomes of patients with 
cancer.  
Consistency and Accuracy of ED Triage 
The triage process ranks ED patients for whom emergency interventions should be 
delivered immediately or shortly in the first and second category respectively, while other 
patients in less urgent categories may wait until a physician is available (Beveridge et al., 
1998). Therefore, it is essential that these triage decisions be precise and accurate 
(Goransson, Ehnfors, Fonteyn, & Enhrenberg, 2008). Precision and accuracy of triage 
have been an ongoing problem, and researchers have tried to introduce different triage 
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scales to enhance certainty in the triage process (Bullard, Unger, Spence, & Grafstein, 
2008). Using a triage scale, the triage nurse performs a brief focused assessment, then 
assigns the patient a triage acuity level. This code serves as a tag to identify how long the 
patient can safely wait before receiving treatment.  
In the limited literature about triage, researchers have explored the type and 
consistency among users of the scales in terms of triage implementation (Chen et al., 
2010). Results from these studies revealed discrepancies between triage nurses in making 
triage decisions using these scales. For instance, the results from surveys using validated 
triage scenarios demonstrated moderate to poor interrater reliability (k = 0.38 - 0.42) 
using the Australian Triage Scale (Considine, Botti, & Thomas, 2007; Ekins & Morphet, 
2015; Gerdtz & Bucknall, 2007). Similarly, the variability of triage score assignment 
using the ESI has been recently identified. In the multinational study, the concordance of 
nurse-assigned ESI scores with a reference standard was universally poor with high 
variability in the triage decisions made (α = 0.44). The authors concluded that there is a 
need for more reliable use by nurses (Mistry et al., 2017).  
In Canada, similar studies were conducted to assess the reproducibility of CTAS 
with mixed results in reported interrater agreements. Dallaire, Poitras, Aubin, Lavoie, and 
Moore (2012) observed that the CTAS had lower reliability than expected (k = 0.44). 
However, a limitation of the research was the use of hypothetical case scenarios (vignette) 
to evaluate the consistency of triage, which might be non-replicable in real practice. An 
robust trial in Atlantic Canada was conducted to assess the performance of CTAS using 
well-trained nurses who retrospectively triaged actual cases of patients visiting the ED. 
Results revealed moderate strength of agreement in using CTAS in the triage of patients 
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(kw = 0.48, 95% CI = 0.45 – 0.52) (Howlett & Atkinson, 2012). The moderate reliability 
noted in CTAS has resulted in a new electronic version called e-CTAS. The results of a 
prospective cohort study of nurses triaging actual patients in real practice revealed that e-
CTAS has a similar fair agreement using unweighted kappa (k = 0.40) and moderate 
agreement when weighted kappa was used (k = 0.52) between the nurses using it (Dong et 
al., 2006).  
Before we conclude the moderate reliability of CTAS, it is important to mention 
that all these studies failed to indicate which version of the CTAS guidelines was used in 
their evaluation among the multiple revisions that were introduced to the guidelines in the 
years 2004, 2008, 2014, and 2017. Nonetheless, an orphan study by Fernandes and 
colleagues (2013) had the primary objective of assessing the interrater agreement of the 
2008 CTAS guidelines and comparing it to the 2004 CTAS version. The analysis of the 
vignette survey demonstrated that the 2008 CTAS guidelines was less reliable than the 
2004 CTAS guidelines, with a lower level of agreement for the scenarios using the 2008 
guidelines than using the 2004 guidelines (Fernandes et al., 2013). However, this is the 
only study that compared the reliability of the 2008 guidelines to other versions of the 
guidlines. 
The lack of consistency among nurses in making triage decisions can result in  
patients being incorrectly triaged (also known as mal-triage). Multiple studies have 
revealed the problem of mal-triage. For instance, Howlett and Atkinson (2012) reported 
that the assigned triage scores were inconsistent with the CTAS recommendations in 
about one-third of ED patients. Also, the accuracy of triage decision-making is found to 
decrease with each less urgent triage category (Ekins & Morphet, 2015). Therefore, 
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patients who present without life-threatening conditions are more likely to be assigned a 
less urgent triage categories. Cancer patients can easily fall into this category by 
presenting with complaints that include but are not limited to fever, fatigue, insomnia, 
diarrhea, and constipation (Gobel et al., 2009).  
A patient who is mal-triaged can either be over-triaged or under-triaged. Under-
triage occurs when a patient is assigned a level of urgency that results in the patient 
waiting longer than is appropriate for a condition that brought the patient to the ED. Over-
triage, on the other hand, is described as making decisions that result in an individual 
being assigned an acuity rating that is higher than is considered necessary (Chen et al., 
2010). In one of the studies evaluating the validity of triage, patients were over-triaged 
and under-triaged at the rate of 24% and 33%, respectively. Multiple problems in the 
triage process were also identified including the lack of consistency in assessing pain and 
measuring vital signs during the triage assessment (not used in the triage of 32% and 18% 
of the patients, respectively) (Howlett & Atkinson, 2012). For instance, patients with 
oncological complaints were found to be more likely assigned to lower triage categories 
(less urgent) despite the greater urgency or severity of their manifestations (Oatley et al., 
2016). Moreover, around 35% of cancer patients with FN, the most life-threatening 
oncological emergency, were found to be under-triaged (Szwajcer et al., 2011). Similarly, 
Livingston, Craike, and Slavin (2012) showed that 30% of ED episodes of FN were 
inappropriately triaged to lower acuity ratings (less urgent).  
Patients who are under-triaged have the potential to experience serious adverse 
outcomes, or leave ED without being seen, resulting in potential hazards to their health 
(Ding et al., 2006). On the other hand, over-triage is reported as a standard action that is 
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practiced by most nurses. Though it seems safer, over-triage has the potential to increase 
wait times for patients who do need to be seen rapidly, and thus may adversely affect 
these patients (Olofsson, Gellerstedt, & Carlstrom, 2009). 
From another perspective, it was also reported that discrepancies in acuity 
assignation are not distributed equally among the visitors of ED. For example, patients 
with cancer are very likely to be assigned a lower triage score (less urgent) (Swenson et 
al., 1995; Nirenberg et al., 2004; Oatley et al., 2016; Szwajcer et al., 2011). Even the 
impact of under-triage can vary significantly among patients with different presentations. 
For instance, under-triaging cancer patients with FN can result in serious complications or 
even death (Szwajcer et al., 2011). FN is considered an oncological emergency that arises 
mainly from the treatment of cancer where patients suffer from a profound bone marrow 
suppression that leaves them susceptible to severe infections (Weycker et al., 2016). In 
the prospective multiple cohort study (N = 497), delayed ED care and increased wait 
times were found to be associated with adverse outcomes among patients with FN (Keng 
et al., 2015). 
The Objectivity of the Triage Process  
While a delay in emergency care and extended wait times can begin with the 
urgency ratings assigned, the inaccurate score may be due to the beliefs that are held by 
emergency nurses toward cancer patients. The lack of objectivity and the resultant 
inconsistencies in triaging patients were documented in several studies (Considine et al., 
2007; Dallaire et al., 2012; Dong et al., 2006; Ekins & Morphet, 2015; Gerdtz & 
Bucknall, 2007). In one of the most extensive studies where hundreds of charts were 
reviewed from 30 different EDs, it was reported that triage documentations were 
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inconsistent, incomplete, and inaccurate, often just quoting patients’ complaints. Also, the 
results from a multicentre retrospective cohort study revealed that triage nurses lacked a 
systematic approach to investigate cancer patients’ underlying reasons for seeking 
emergency care (Berger & Gillespey, 2002). Similarly, a British study reported that the 
triage nurses assigned acuity ratings based on the physical appearance of the patients and 
this can be problematic. Such immediate intuitive evaluation of patients’ presenting 
complaints is not only unreliable but also promotes a culture of stereotyping where 
patients are being judged by their appearances (Edwards, 2007).  
It is not known whether Canadian triage nurses use similar approaches, but this 
intuitive approach to triaging patients is contradictory to the primary objective of any 
triage guidelines, namely, to make the triage process more objective, and therefore, more 
consistent (Beveridge et al., 1998). Nevertheless, other studies have also demonstrated a 
lack of objectivity in implementing triage where personal attitudes, beliefs, and biases 
were found influential in determining triage decisions (Stanfield, 2015). Moreover, many 
triage nurses were not able to describe their organizations’ triage scale or even 
demonstrate familiarity with important decision modifiers such as risk factors, pain, and 
immunocompromised status (McNairy, 2005). Cooper, Schriger, Flaherty, Lin, and 
Hubbell (2002) highlighted an alarming problem in the triage process where knowing the 
vital signs of the ED patients did not change the assigned triage score; indeed, 92.1% of 
triage decisions were not affected by knowing the patient’s vital signs. Although this was 
an American study, a comparable Canadian study reported similar results where pain 
assessment and vital signs measurement were not considered in the triage of 32% and 
18% of the ED patients, respectively (Howlett & Atkinson, 2012). It is true that the 
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
 
19 
presenting complaints are only valid to determine the complaint-specific minimum CTAS 
level. However, specific risk modifiers such as vital signs are considered essential first-
order modifiers that need to be applied and can be used to change the initial anticipated 
triage acuity level (Murray et al., 2004). For example, the CTAS recommendations for the 
triage of cancer patients who receive chemotherapy is to look for the presence of fever 
(querying them for FN), and therefore, ignoring the vitals of these patients can result in an 
inappropriate assessment and misclassification with catastrophic complications (Bullard 
et al., 2017). However, reports are lacking for an up-to-date evaluation of the 
performance of triage in real-world practice. 
Factors Influencing the Process of ED Triage  
The process of triage decision making is a complex one, where the triage nurse 
uses a variety of thinking strategies, which range from searching for information, 
generating hypotheses, to allocating acuity ratings (Chen et al., 2010; Goransson, 
Ehrenberg, Marklund, & Ehnfors, 2006). Adding to this complexity are the many factors 
that influence the triage decision-making process. These factors can be categorized as 
internal factors, which are nurse-related, and external factors, which correspond to the 
environment. The internal factors reflect nursing skills and personal capacity. Nursing 
skills include knowledge, years of emergency triage experience, and clinical judgment of 
the nurse to have real insight and intuition. The individual ability reflects the unique nurse 
characteristics of being courageous, confident, and rational in making decisions 
(Andersson, Omberg, & Svedlund, 2006). However, the results from a Swedish study of 
423 registered nurses from 48 Swedish EDs who individually triaged 18 patient scenarios 
using the CTAS guidelines found no significant association between personal 
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characteristics of the registered nurses and their ability to triage (Goransson et al., 2006). 
In the ethnographic study by Wolf (2010), an in-depth exploration of ten emergency 
nurses with eight to 38 years of nursing experience identified that acuity determination is 
influenced by external factors such as patient volume, unit leadership, communication 
with patients and providers, and time constraints. Andersson et al. (2006) identified 
different but similar abstract external factors that can have an effect on the triage decision 
such as the working environment in terms of the high workloads and practical 
arrangements within the ED. However, Dong et al. (2006) challenged this information 
and argued that ED crowding was not a determining factor in the accuracy of triage 
decision-making. They conducted a prospective observational study of two groups of 
nurses to assess the reliability of e-TRIAGE (a web-based triage decision support tool) 
for assigning triage levels to patients in real practice in one of the largest EDs in Canada. 
They identified factors such as the chief complaints, the age of the patient, vital signs, 
pain score, and past medical history as determinants of the triage acuity ratings (Stanfield, 
2015).  
Clinical experience is generally assumed an essential requisite in the challenging 
role of ED triage nurses. Nursing managers understand that senior nurses are the most 
qualified in making triage decisions. Some studies examined the relationship between 
triage decisions and knowledge and experience of the triage nurses. However, no 
significant association was documented between the general experience of the triage 
nurse and the ability to make correct triage decisions (Considine et al., 2007; Martin et 
al., 2014). Factual knowledge appeared to be a more critical factor than years of 
emergency nursing experience or experience in triage (Considine et al., 2007; Wolf, 
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2010). For example, in a randomized control trial of senior-level nursing students, the 
addition of an Advanced Cardiac Life Support (ACLS) course to the experimental group 
promoted confidence in triage decision-making. Confidence in triage decision making 
was assessed by the Triage Decision Making Inventory (TDMI). The instrument measures 
characteristics such as experience level, critical thinking, and intuition use as an indicator 
of personal characteristics distinguishing expert triage nurses (Smith et al., 2013). Martin 
and colleagues (2014) conducted a retrospective cohort study to examine if there was a 
difference in nurse attitudes and experience for those who assign Emergency Severity 
Index (ESI) scores accurately and those who did not assign ESI scores accurately. The 
results of analyzing 64 nurse participants’ triage decisions identified that the ESI score 
assigned by nurse participants did not differ significantly based on years of experience. 
Understanding the triage tool and possessing the knowledge were found to be reliable 
indicators of nurses’ capacities to make safer triage decisions. The authors of these 
studies provide some evidence that if nurses possess the proper knowledge, they can 
make safe and appropriate triage decisions. Yet, the results from these studies provided 
inconclusive evidence because the employed designs were a retrospective assessment 
using low fidelity simulation (vignette surveys). There likely is a complex interaction of 
multiple factors that affect the triage assessment in real-world practice which can be 
challenging to capture or replicate in such artificial environment (Fitzgerald, Jelinek, 
Scott, & Gerdtz, 2010). 
Febrile Neutropenia  
Febrile neutropenia (FN) is considered among the most common side effects 
related to cancer treatment (Bryant et al., 2015; Nirenberg et al., 2004; Vandyk et al., 
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2012). FN is a potentially life-threatening oncologic emergency, which requires prompt 
emergency care (Lim et al., 2011; Meer et al., 2016; Samphao, Eremin, & Eremin, 2010). 
FN is defined as “a low neutrophil count of 1.5 × 109 /L and single oral temperature 
measurement of more than 38.3°C or a temperature of more than 38.0°C sustained over 
one-hour period” (Freifeld et al., 2011, p. e61). The risk of FN with cancer treatment is 
about 17% with higher expected risk repeated chemotherapy cycles (Oatley et al., 2016; 
Weycker, Barron, Kartashov, Legg, & Lyman, 2014). Other studies reported higher rates 
occurring in half of the patients receiving chemotherapy (Hashiguchi et al., 2015).  
Fever is a common symptom that often occurs in association with minor 
conditions. However, fever occurring in cancer patients may be the only manifestation of 
a severe underlying infection as signs and symptoms of inflammation are typically 
attenuated (Freifeld et al., 2011). Bone marrow suppression is an expected side effect of 
many chemotherapy regimens with the majority of chemotherapeutic drugs having a 
cytotoxic effect (Adelberg & Bishop, 2009). Infection due to neutropenia is associated 
with significant morbidity and mortality in patients receiving chemotherapy (Walji et al., 
2008). FN patients can present with sepsis at the ED as they may be experiencing subtle, 
severe underlying infection (Prachanukool, Tangkulpanich, Paosaree, Sawanyawisuth, & 
Sitthichanbuncha, 2016). However, fever can be the only presentation, or patients may be 
afebrile (Adelberg & Bishop, 2009; Freifeld et al., 2011). Patients with cancer are four 
times more likely to present with severe sepsis compared with non-cancer patients (Hsu et 
al., 2018). Therefore, in the context of triage and the CTAS guidelines, all patients on 
chemotherapeutic agents or who are immunocompromised come under the category of 
FN if they present to ED with fever alone (Beveridge et al., 1998).  
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Morbidity and Mortality of Febrile Neutropenia  
FN has considerable clinical consequences such as dose reductions, delays, or 
even discontinuation of chemotherapy, and is associated with substantial mortality, 
morbidity, and costs (Lyman, Abella, & Pettengell, 2014). Chevalier et al. (2011) 
reported that FN resulted in 12% mortality, 24% changing the chemotherapy regimen, 
and 28% terminating the chemotherapy treatment. FN is potentially life-threatening 
where failure to implement immediate treatment can be associated with rapid progression 
to septicemia. Empiric antibiotic therapy should be initiated promptly as delayed 
initiation of antibiotics can be associated with increased mortality (Adelberg & Bishop, 
2009; Gabriel, 2012; Livingston et al., 2012). Early antibiotic administration is associated 
with fewer complications and higher survival rates among patients with FN (Lynn et al., 
2013; Rosa & Goldani, 2014). Despite such benefits, delayed emergency care and 
prolonged time to antibiotics have been found in many observational studies (Nirenberg 
et al., 2004; Oatley et al. 2016; Szwajcer et al., 2011). 
FN can leave a heavy burden on patients as well as the health care system. This 
burden can get inflated if patients were exposed to unnecessary delay in treatment where 
delay is associated with significant complication of sepsis with a prolonged length of stay 
(Keng et al., 2015; Klastersky, 2004; Koh & Pizzo, 2002). Generally, these ED visits 
were found unavoidable and resulted in the majority of patients being urgently admitted 
(Nirenberg et al., 2004; Oatley et al., 2016). Infection accounts for 14% of cancer-related 
admissions (Numico et al., 2015). Of the studies that evaluated the health care system 
burden of FN, 13 days of hospital stay were reported with associated costs of $22,800 
(Kuderer, Dale, Crawford, Cosler, & Lyman, 2006). The mean LOS in the ED for those 
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patients ranged from 5.5 to 8.1 hours (Livingston et al., 2012; Nirenberg et al., 2004; 
Oatley et al., 2016). The median time from the diagnosis of FN to the ICU admission was 
10 hours (Strojnik, Mahkovic-Hergouth, Novakovic, & Seruga, 2016). The average 
hospital LOS for cancer patients with FN was 7.1 days (Oatley et al., 2016). Marked 
variability was observed concerning hospital LOS associated with FN among different 
cancer types and treatment with an average range of 7 to 14 days for hospital LOS 
(Kawatkar et al., 2017; Strojnik et al., 2016; Weycker et al., 2014). The mortality rate 
associated with FN in cancer patients is between 5% and 20% and can reach up to 75% 
(Barber, 2001; Courtney et al., 2007; Kawatkar et al., 2017; Kuderer et al., 2006; Lim et 
al., 2011). Among patients admitted into the ICU with FN, 45% died during their hospital 
stay. Certain variables were associated with poor outcomes such as intubation and 
mechanical ventilation support, allogeneic bone marrow transplantation, microbiological 
documentation of the infection, and the need for hemodialysis (Mokart et al., 2015). 
Prevention of Febrile Neutropenia  
Naturally, FN is associated with a heavy burden on healthcare in terms of 
morbidities and mortality. FN is a predisposing factor for sepsis, and therefore, 
prevention of FN is an important strategy to reduce morbidity and mortality (Paddock, 
Grock, Deloughery, & Mason, 2017). Consequently, researchers were interested in 
developing strategies to minimize the occurrence of FN by the use of growth factors and 
prophylactic antibiotic administration (Cullen & Baijal, 2009; Ganti, Marini, Nagel, 
Bixby, & Perissinotti, 2017; Taplitz et al., 2018).  
Prophylactic administration of growth factors such as Filgrastim (G-CSF) has 
been associated with a lower incidence of FN (Kawatkar et al., 2017). However, despite 
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their benefits in decreasing the frequency and severity of FN, growth factors are 
underused. The results from a retrospective cohort study demonstrated an underuse of G-
CSF among patients with FN as Filgrastim was administered to only 62% before their ED 
presentation (Szwajcer et al., 2011). In the French prospective, multicentre cohort of 
critically ill cancer patients with FN, the authors reported that G-CSF was initiated in the 
ED for only 10% of the patients (Andre et al., 2010). Similar results were also reported 
for the underuse of outpatient prophylactic antibiotics administration. For instance, 
Courtney et al. (2007) showed that among patients who were admitted with FN, around 
67% were on prophylactic antimicrobial medications at home before the presentation. 
Ganti and colleagues (2017) conducted a retrospective cohort study of adult patients with 
relapsed/refractory acute myeloid leukemia who were admitted for reinduction 
chemotherapy over ten years to evaluate the impact of antibacterial prophylaxis with 
levofloxacin in relapsed/refractory acute leukemia. Their results showed that the benefits 
of using antibiotic prophylaxis outweighed the risk of antibiotic resistance because their 
use was associated with a decrease in time to bacteremia, time to neutropenic fever, and 
reduction in the incidence of infections. 
Risk Stratification of Febrile Neutropenia  
Multiple scoring systems have been invented to assess the seriousness of FN such 
as the MASCC (Multinational Association for Supportive Care in Cancer) and CISNE 
(Clinical Index of Stable Febrile Neutropenia) (Coyne et al., 2017). Since CISNE requires 
some invasive examination such as monocytes count, I will only focus on MASCC 
because of its convenience for use at triage. 
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The calculated MASCC score categorizes patients with FN into low and high risk 
based on a scoring system. Low-risk FN patients are considered stable and eligible for 
outpatient management with oral antibiotics (Paddock, Grock, Deloughery, & Mason, 
2017). High-risk patients should be admitted to the hospital with an immediate IV broad-
spectrum antibiotic administered in the ED. While a number of researchers and clinicians 
disagree with outpatient management of low-risk FN, the recommendations of different 
FN guidelines is that these patients receive initial doses of empiric antibacterial therapy 
within one hour of triage and be monitored for four hours before being discharged 
(Cancer Care Nova Scotia, 2014; Taplitz et al., 2018). Patients who do not get well after 
two to three days should be re-evaluated and considered for an inpatient treatment 
(Taplitz et al., 2018). Table 1 summarizes patient characteristics that are needed to 
calculate the MASCC score.  
Table 1 
MASCC Scoring System 
Characteristic Score 
The burden of FN with no or mild symptoms 5 
No hypotension (i.e., systolic blood pressure > 90 mmHg) 5 
No chronic obstructive pulmonary disease 4 
Solid tumor or hematologic malignancy with no previous fungal infection 4 
No dehydration requiring parenteral fluids 3 
Outpatient status 3 
Age < 60 years  2 
Note. Reprinted from “Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical 
Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update,” by Taplitz, R., Kennedy, E., Bow, E., Crews, J., 
Gleason, C., Hawley, D., . . . Flowers, C. (2018). Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: 
American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. Journal of Clinical 
Oncology, 36(14), 1443-1453. Copyright 2018 by “American Society of Clinical Oncology.” 
 
 The total score on the MASCC is calculated by adding the individual score of 
each of the eight criteria comprising the scale. If the answer is yes to each of the criteria 
above, a patient gets the score on the right of the table. For example, if the systolic blood 
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pressure was more than 90 mmHg, then the patient is scored ‘5’ on this criterion. Any 
patient with a MASCC score of ≥ 21 is considered to have a low-risk FN (Klastersky et 
al., 2007). However, Coyne et al. (2017) conducted a retrospective cohort study to 
evaluate all patients with FN (temperature ≥38°C, absolute neutrophil count <1,000 
cells/μL) who presented to 2 academic EDs over three years. The MASCC score was 
calculated for all subjects, and each visit was evaluated for several outcomes to include 
inpatient length of stay, upgrade in level of care, clinical deterioration, positive blood 
culture results, and death. Their results were alarming in that 16% of ED patients who 
were identified as low risk by MASCC score were found to have severe adverse events. 
According to Paddock et al. (2017), the sensitivity and specificity of the MASCC “might 
be good in Vegas but not in the ED” (p. 766). Moreover, Strojnik, Mahkovic-Hergouth, 
Novakovic, and Seruga (2016) retrospectively analyzed all adult cancer patients with FN 
with severe infection who were admitted to the Intensive Care Unit (ICU) over ten years. 
Their results were congruent with FN guidelines as they found that 13% of patients with 
neutropenic infections who were afebrile, were identified as high-risk with a median 
MASCC score of 13.  
Uncertainties in the ED Management of Febrile Neutropenia 
With the introduction of outpatient chemotherapy, where more than one-third of 
cytotoxic drugs are administered orally, patients have experienced an increase in the 
severity of treatment toxicities believed to be due to a reduction in contact with oncology 
care providers (Considine, Livingston, Bucknall, & Botti, 2009; Parsad & Ratain, 2007; 
Walji, Chan, & Peake, 2008). The ED is an accessible entry point for patients requiring 
immediate healthcare services (Barbera et al., 2012; Vandyk et al., 2012). Notably, when 
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there is insufficient primary and outpatient care for patients, the ED becomes the only 
place to manage oncological severe emergencies such as FN (Barbera, Taylor, & 
Dudgeon, 2010; Bosscher, Leeuwen, & Hoekstra, 2015; Brown et al., 2016; Sadik et al., 
2014). This is evident in the results from an up-to-date systematic review of cohort and 
randomized controlled studies indicated higher rates of ED use among patients with 
cancer (Lash et al., 2017). 
The standard of care for patients with FN is to receive a timely empiric antibiotic 
administration to prevent the development of sepsis (Weycker et al., 2016). The concern 
for the prompt treatment of cancer patients in the ED is mainly due to the risk of 
infection. Infections remain a significant cause of morbidity and mortality among cancer 
patients with FN. Therefore, the Infectious Diseases Society of America (2010) has 
updated the clinical guidelines for the use of antimicrobial agents in neutropenic patients 
with cancer and promoted the immediate administration of a broad-spectrum antibiotic to 
all ED patients who are suspected to have FN, whether they present with or without fever 
and before the confirmation of neutropenia (Freifeld et al., 2011). However, patients with 
FN can be unrecognized due to attenuated inflammatory manifestations. This is evident in 
delayed emergency care and prolonged time to antibiotics (TTA), which have been 
illustrated in many epidemiological studies. For instance, in a retrospective cohort study 
of a random sample of cancer patients (n = 1110 episodes) who presented to one ED, the 
results showed that patients with FN (n = 286) experienced at least three-hour wait times 
after triage before the administration of antibiotics (Oatley et al., 2016). Similarly, 
Nirenberg et al. (2004) retrospectively followed patients with confirmed FN (n = 33) and 
reported a median TTA of 3.5 hours. Another retrospective cohort by Szwajcer and 
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colleagues (2011) reported a longer delay where patients with FN (n = 68) received their 
antibiotic after five hours with only 6% of the patients receiving antibiotics within two 
hours of triage. Moreover, this delay was associated with a longer time for the release of 
laboratory values for at least five hours after admission which could have prevented 
crucial decisions being made regarding the plan of care (Nirenberg et al., 2004).  
In the largest retrospective cohort study of 2,731 adult patients with early signs of 
sepsis from 14 ICUs in Canada and the United States, the time to initiation of effective 
antimicrobial therapy was reported to be the single most reliable predictor of outcome 
with 8% drop in survival for every hour of delay (Kumar et al., 2006). In another 
retrospective chart review of 100 adult cancer patients presenting to an ED with sepsis 
without hypotension, Morneau et al. (2017) reported that each hour of delay in 
administration of appropriate antibiotic therapy increased the odds of in-hospital mortality 
by 16%. The results from an up-to-date meta-analysis provided strong evidence for early 
management in the ED, suggesting a significant 33% reduction in mortality odds for 
immediate (within 1 hour) antibiotic administration (Johnston et al., 2017). Furthermore, 
accumulated evidence supports that delayed ED care and increased wait times were 
associated with adverse outcomes among patients with FN (Keng et al., 2015; Klastersky, 
2004; Koh & Pizzo, 2002), while earlier administration of antibiotics was associated with 
fewer complications (Lynn et al., 2013).  
The concern for the management and treatment of patients with FN in the ED is 
nothing new (Freifeld et al., 2011; Leak et al., 2012; Nirenberg et al., 2004; Oatley et al., 
2016; Swenson et al. 1995; Szwajcer et al., 2011). However, I believe that these concerns 
should continue because the delays and wait times reported in these studies are coupled 
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with other research findings, suggesting that cancer patients had higher mortality 
compared to other ED patients (Considine et al., 2009). Furthermore, the results from a 
retrospective cohort study suggested an ED visit was an indicator for poor survival among 
patients with oncological emergencies on the basis that 36% of those patients died within 
12 months of their ED presentation (Oatley et al., 2016). Moreover, the cross-sectional 
analysis of ED visits from the national database in the US identified that 71% of patients 
with oncological emergencies who died in the ED, did so on their first visit (Leak et al., 
2012). Similarly, results from an American outcome study (N = 16,038), which examined 
risk factors for ICU admission and hospital death among patients with oncological 
emergencies who were admitted through the ED, reported patients experiencing a higher 
ICU admission rate and hospital mortality (Elsayem et al., 2014).  
Admission to ICU for patients with FN may indicate that patients are having 
severe neutropenia and/or witnessing complications (Courtney et al., 2007). For instance, 
in one study in which a quarter of patients with FN were admitted to the ICU, around 
75% died due to complications associated with FN. Patients with FN who required ICU 
care had a significantly higher mortality rate than those who did not require ICU care 
(Courtney et al., 2007). The results from a prospective cohort study of 1,011 patients who 
were admitted to the ICU, showed that 45% of the patients with FN died during their 
hospital stay (Mokart et al., 2015). Sadik et al. (2014) reported a higher rate of mortality 
in the retrospective review of 408 cancer patients who visited the ED in which death was 
witnessed in 47% of patients. The most common underlying reasons for ICU admission 
were septic shock (57%) and severe sepsis (29%) with a median ICU LOS of 5 days 
(range 1–34 days) (Strojnik et al., 2016). Abou Dagher and colleagues (2017) conducted a 
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retrospective cohort study (n = 352) of cancer patients with sepsis and found that they 
were similar to other septic patients regarding ED and ICU LOS. However, cancer 
patients with sepsis were more likely to die compared to patients who did not have 
cancer. The 28-day hospital mortality rate was double in the cancer group when compared 
to other septic patients (49%, 26%, respectively). A high percentage of death (27%) was 
also documented in a retrospective cohort of patients (n = 452) who presented with a 
simple complaint or even were hospitalized for symptom management (Numico et al., 
2015). 
Knowledge and understanding of the unfortunate outcomes among cancer patients 
with FN are the keys for any change to occur. Some studies highlighted that patients with 
FN were not accurately identified, nor appropriately triaged. For instance, an Australian 
retrospective study in an ED setting which uses a similar triage system to CTAS reported 
that around 80% of patients with oncological emergencies were inappropriately allocated 
to lower triage categories of 3, 4, and 5 (60%, 18%, 2%, respectively) (Oatley et al., 
2016). Similarly, a Canadian retrospective cohort study of multicenter EDs with highly 
restrictive inclusion criteria of only patients with confirmed fever and neutropenia, 
reported that at least one-third of patients with definitive FN had received a lower-than-
appropriate acuity rating. Although the other two-thirds of patients had received an 
appropriate acuity score, they were not seen within the CTAS guidelines benchmark time 
with a minimum one hour of delay to reassessment during their waiting at triage 
(Szwajcer et al., 2011). It is reasonable to find these results among FN patients because 
even patients with common, chronic conditions such as myocardial infarction were found 
to be mal-triaged. For example, a retrospective cohort study was conducted at the 
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University of Toronto of 11,510 patients who visited 102 EDs to examine the effect of the 
ED triage score on acute myocardial infarction quality of care. The study results showed 
that half of the patients with typical ST elevation acute myocardial infarction were 
assigned to a triage level of 3, 4, and 5 (43%, 5%, and 2%, respectively). Also, this 
inappropriate under-triage was reported as having a significant and independent effect, 
causing substantial delays in ECG acquisition and reperfusion therapy. The authors 
concluded, “the quality of ED triage may be an important factor limiting performance on 
key measures of quality of acute myocardial infarction care” (Atzema et al., 2009, p.742). 
The allocation of patients with FN to less urgent triage categories can be 
responsible for these patients not reaching the standard benchmark for TTA as 
recommended by the FN guidelines (Nirenberg et al., 2004; Oatley et al., 2016; Szwajcer 
et al., 2011). Therefore, the rapid identification of these patients and prompt initiation of 
treatment have been recommended as an effective strategy for better patient outcomes for 
decades (Shelton, 1999). ED triage nurses must be keenly aware of the infection risks 
when prioritizing patients. Fever may be the only indication of severe underlying 
infection because the signs and symptoms of inflammation among cancer patients are 
typically attenuated (Freifeld et al., 2011). 
Gap in Current Quality Improvement (QI) Initiatives 
In the previous discussion, we highlighted the fundamental role of triage in 
determining the course of patients’ care within the ED. However, we documented some 
critical issues concerning the implementation of triage, suggesting an increased concern 
for the effectiveness and even the safety of its use among patients with FN. There is a 
reliability problem where triage decisions are discrepant and vary on different occasions 
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and between different triage nurses. Consequently, some patients can be mal-triaged 
where they receive triage scores that are not appropriate for the urgency of patient 
presentations. However, there is a considerable gap in the current literature; published 
studies were only concerned with the consistency of the implementation of triage and 
neglected the primary objective for instating triage, specifically the improvement of 
patient outcomes. In this study, I am taking a different approach in the investigation of 
ED triage, I will evaluate the accuracy of triage implementation and the impact on the 
treatment outcomes. Related to my approach, before I conclude this chapter, I will present 
some QI initiatives that were examined in the literature to improve the quality of ED care 
among patients with FN. These clinical solutions will be examined to identify the 
limitations in such practices despite their aim at improving the efficiency and timeliness 
in the ED management of patients with FN.  
Education. Education is a significant factor in improving the quality of care 
nurses provide; specialized knowledge such as that contained in nurse certification 
programs has been shown to lead to higher quality care, even when nurses have little 
experience. The available evidence to date supports knowledge as the determining factor 
of the accuracy of triage decisions (Chen et al., 2010; Ekins & Morphet, 2015; Martin et 
al., 2014; Smith et al., 2013).  
Education has been frequently considered the cornerstone of any desired change at 
the individual level (Grol et al., 2013). Education has a vital role in advancing the skills 
and capabilities of nurses. Evaluation of the efficiency of a registered nurse is no longer 
dependent on years of experience, but extends to include specialized knowledge. Reliance 
on experience alone is no longer considered adequate for making accurate triage decisions 
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(Considine et al., 2007; Martin et al., 2014). Triage nurses may lack the relevant scientific 
information regarding the urgency of oncological emergencies (Considine et al., 2007; 
Wolf, 2010). Therefore, it may be essential to provide them with the necessary education 
to anticipate the urgency of patients with various presentations. However, enhancing the 
knowledge of triage nurses is no guarantee for an accurate triage decision when the 
environment is not supportive. For example, formulating policies, guidelines, and 
pathways is no guarantee that people will make use of those resources (Grol et al., 2013).  
The assumption behind many triage educational programs is that acquiring 
knowledge will improve triage decisions. Furthermore, at this basic individual level, 
education strategies should address the need to be objective in the triage process and to 
promote compliance in using the guidelines. The assignment of a triage acuity rating is 
expected to be more objective and less open to debate (Bullard et al., 2008). Such a desire 
for objectivity in triaging patients has led to the development of a computerized aided 
triage decision-making tool (Dong et al., 2006). However, the use of education or 
decision supports may not help in improving the triage process. In chapter two, we will 
elaborate more on this conclusion as we examined the computerized aided triage being 
used among oncological emergencies. 
Moreover, to educate the triage nurses about the urgency of FN with the intention 
of improving its recognition for prompt management can be ineffective if patients present 
late at triage. This was evident in pre-hospital delay for a mean time of 21 hours before 
seeking emergency care by patients with FN (Nirenberg et al., 2004). Therefore, 
education that is provided to the triage nurses about the risks and complications of FN is 
equally essential to the knowledge that should be provided to the patients. 
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Clinical Pathways and Guidelines. Many hospitals established or adapted 
different algorithms, protocols, or standardized order sets to lower the TTA 
administration among patients with FN as recommended by FN guidelines. The rationale 
is that specific hospital pathways may be designed for particular patients to improve their 
access to ED care and consequently their health outcomes (Kennelly et al., 2014). For 
example, Richards and colleagues (2011) developed and validated a novel palliative 
medicine needs assessment tool for patients with cancer in the ED. The instrument was 
based on the understanding that certain patients who seek emergency care presented with 
complex problems that they were unable to communicate effectively. This may be due to 
their acute distress and provider time constraints. Therefore, the instrument was 
developed as a brief, multidimensional symptom assessment tool designed to be 
comprehensive, yet rapid, in the assessment of domains of palliative care in an ED. 
To further enhance the triage process, resources such as clinical guidelines should 
be readily available for emergency nurses to complement their professional judgment 
(Molina, Seow, Heng, Chong, & Ho, 2014). However, clinical guidelines can be 
ineffective unless they are being operationalized within the system using protocols or 
clinical pathways. For instance, in one quality initiative, Keng et al. (2015) conducted a 
prospective multiple cohort study (n = 497) to assess whether the Febrile Neutropenia 
Pathway (FNP) could reduce antibiotic delays and improve quality of care for patients for 
a prompt antibiotic administration. Interestingly, their results demonstrated that the 
implementation of FNP decreased the time to antibiotic administration by almost two 
thirds. The time for antibiotic administration was reduced from around 4 hours to 81 
minutes, and when a pre-order set was used, the time was further reduced to about an 
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hour (Keng et al., 2015). This study illustrated the magnitude of the effect that ED wait 
times can have on treatment outcomes. When the change targeted the ED process that was 
responsible for the delay in the treatment of cancer patients, it resulted in dramatic fast 
tracking of those patients with a quicker time to the administration of the required 
antibiotics and shorter hospital length of stay (Keng et al., 2015). 
Similarly, Kapil et al. (2016) evaluated the implementation of fever alert cards 
(FACs) as a communication tool to decrease the time required for administration of 
antibiotics in patients with FN who present to the ED. The implementation of FACs has 
helped to improve FN recognition with a higher percentage of patients obtaining a correct 
urgency rating, which suggests improvement in FN recognition. However, this did not 
translate to improvement in TTA administration. These results support that the assigned 
triage acuity rating is not the only determinant of ED care and other factors within the 
emergency setting are expected to influence the care provision.  
A Cancer Unit within the Emergency Department. The change can take a 
different form by redesigning the way cancer patients are managed within the ED. To 
meet the needs of patients with cancer and facilitate the management of their oncological 
complaints, one of the suggestions was to introduce a cancer unit within the emergency 
setting. Ruegg (2013) argued that an ED unit for patients with cancer could have a 
valuable role in assessing and managing oncological emergencies. Such an ED unit is 
essential to control not only the progression of the disease, but also to treat various 
toxicities and complications related to treatments and link them to hospice and palliative 
care. These new urgent care models were designed with the intention to benefit cancer 
patients by providing specialist services that optimize safety, access, and timely care 
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(Oatley et al., 2016). Ruegg (2013) suggested that NP-led oncology urgent care clinic 
within the ED can serve as a vital alternative for meeting the immediate complex needs of 
patients with FN. However, Ahn, Lee, Lim, and Lee (2012) found that the cost of these 
units is not justified or even beneficial when it cannot reduce the length of stay or rate of 
admission within the ED.  
Other strategies have looked at diverting cancer patients from ED triage by 
redesigning emergency care and providing different pathways to care. The need for this 
was established by the findings from many studies which revealed that despite FN being 
an established oncological emergency, many patients suffered significant delays seeking 
emergency care (Nirenberg et al., 2004; Oatley et al., 2016; Szwajcer et al., 2011). 
However, the diversion of such patients may not be useful, but may also be harmful. 
Indeed, long care delays within the ED are related to waits for ED beds; therefore, 
diverting away from the ED patients who were assigned to low acuity level of IV and V 
patients would only minimally reduce the demand for ED beds and only minimally 
impact wait times. Also, a small proportion of CTAS level IV and V patients do end up 
requiring admission and triaging them away from the ED could result in adverse 
outcomes (Vertesi, 2004). Furthermore, there is evidence that FN patients who were 
identified as low risk by MASCC score and therefore determined eligible for outpatient 
management, subsequently had severe adverse outcomes (Coyne et al., 2017; Klastersky 
et al., 2007). Despite the risk of hospital acquired infection and cost, the admission of 
patients with FN remains the cornerstone of the safer treatment (Paddock et al., 2017). 
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 Summary 
In evaluating the literature that investigates the process of emergency triage for 
individuals with FN, findings indicated many uncertainties in the triage process and the 
subsequent long wait times for care. To date, consistency and the accuracy of triage 
decisions are lacking, and it is unclear which factors can be attributed to these ED delays 
and the subsequent adverse outcomes. In the reviewed literature, studies examining ED 
triage did not differentiate whether the cause of mal-triage was (1) inappropriate 
application of the CTAS by the triage nurse, (2) an inherent problem within the CTAS 
guidelines system itself, or (3) difficulty in identifying FN. Triage performance has been 
measured through representative case evaluation and scoring by triage nurses using 
classroom-based testing methods, and this does not lead to evidence for outcome-based 
decisions (Howlett & Atkinson, 2012).  
The effectiveness of ED triage has to be monitored according to the 
recommendation of CTAS establishers to validate the hypothesis that CTAS is a 
classification system that enhances ED management and performance outcomes. Authors 
have studies highlighted the need for research to assess the accuracy of the triage 
implementation and its impact on patient outcomes. However, to date, the literature is 
lacking these studies, with the exception of one conducted at the University of Toronto 
where it was shown that half of the patients with typical ST elevation acute myocardial 
infarction were assigned to less urgent triage categories. Also, this inappropriate mal-
triage reported having a significant and independent effect causing substantial delays in 
ECG acquisition and reperfusion therapy (Atzema et al., 2009). However, despite these 
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concerning results, to date, the literature is lacking similar studies that determine whether 
ED triage and wait times could be associated with adverse outcomes.  
The available evidence suggests that TTA is an independent determinant of 
mortality for cancer patients with FN. Also, there is consistent evidence indicating that 
admission to the ED may be an essential indicator for lower survival among patients with 
FN (Leak et al., 2012; Numico et al., 2015; Oatley et al., 2016; Sadik et al., 2014). 
Therefore, a change is needed for the process of care; however, any change is not 
meaningful without more research that can explain the exact effect that mal-triage and the 
subsequent time delays would have on patient outcomes. A study is warranted to examine 
whether delayed ED care and adverse health outcomes among patients with FN can be 
attributed to their allocation less urgent triage rating. Patients on chemotherapeutic agents 
or who are immunocompromised (e.g., cancer patients) are supposed to be receiving a 
higher acuity level per the CTAS guidelines. However, the fact that such discriminators 
and risk factors were not familiar terms for most ED triage nurses calls for safety 
measures (Cooper et al., 2002; Howlett & Atkinson, 2012; McNairy, 2005). The literature 
is lacking those studies that can determine the effectiveness of triage in improving the 
treatment and health outcomes of patients with FN. A fundamental question persists about 
whether mal-triage is associated with adverse outcomes among adult cancer patients with 
FN. In the upcoming three chapters, I will present the three manuscripts of my thesis in 
which I answer the research questions raised earlier in this chapter. 
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Do the Canadian Triage Guidelines Identify the Urgency of Oncological Emergencies?  
 
 
Chapter Two 
 
 
 
This chapter constitutes the first manuscript of the thesis. In this manuscript, the CTAS 
guidelines were examined to determine if the urgency of the oncological emergencies was 
identified appropriately in the guidelines. To conduct this analysis, I applied the CTAS 
guidelines using the 2012 complaint-oriented triage (COT) in a simulated triage of select 
oncological emergencies and examined if their urgency can be prioritized appropriately 
using the CTAS guidelines. 
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Abstract 
Background: Triage in an emergency department (ED) plays a pivotal role as the volume 
of ED visitors is unpredictable. All ED patients are triaged to make sure that patients with 
urgent or life-threatening conditions are seen immediately while others with more stable 
conditions are safe to wait.  
Purpose: To examine the Canadian Triage and Acuity Scale (CTAS) guidelines to 
determine if the urgency of oncological emergencies can be prioritized appropriately 
using the CTAS guidelines. 
Methods: We used the Complaint Oriented Triage (COT 2012), which is an interactive 
computerized CTAS tool, to triage select oncological emergencies; superior vena cava 
syndrome, cardiac tamponade, tumor lysis syndrome, and febrile neutropenia .  
Results: Patients with cancer have a higher acuity compared to many other ED patients. 
However, most of the oncological emergencies can be subtle and nonspecific. The CTAS 
guidelines need to be strengthened to better represent the urgency of these life-threatening 
conditions.  
Conclusion: Although revisions have been implemented and the reliability of the CTAS 
tool has improved, the guidelines are designed to be generic and cannot address every 
health situation. Febrile neutropenia is an excellent example of the additional supports 
needed at triage to accurately determine the patient’s health status. Knowledge of the 
signs and symptoms of these emergencies will enable triage nurses to accurately 
differentiate the urgency of the different presenting complaints. Formalized education that 
prepares triage nurses to better understand the complexity of the symptom presentation 
and the needed care for patients with different oncological emergencies is essential. 
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Cancer is a serious public health problem that remains a significant cause of 
mortality worldwide (Benny, 2015). In Canada, cancer is the leading cause of death and is 
responsible for 30% of all deaths. Prevalence of cancer is also on the rise with improved 
survival due to advances in treatment and targeted therapy (Canadian Cancer Statistics, 
2017). However, treatment continues to be aggressive causing severe complications and 
contributing to the prevalence of cancer-related emergencies (Khan, Shanholtz, & 
Mccurdy, 2017; Iacobellis et al., 2018).  
The emergency department (ED) is considered an important entry point into 
health care for individuals with cancer requiring urgent treatment (Oatley, Fry, & Mullen, 
2016). In the ED, patients are sorted by priority in a triage process, which plays a pivotal 
role as the volume of ED visitors is unpredictable. All ED patients are triaged to make 
sure that patients with urgent or life-threatening conditions are seen immediately while 
others with more stable conditions are safe to wait (Bullard et al., 2017). However, the 
assessment and identification of seriously ill oncology patients is problematic as patients 
can present with non-specific symptoms, which could lead to extensive delay in ED 
treatment and negative health consequences (Livingston, Craike, & Considine, 2011). 
Findings from available studies revealed that most cancer patients suffer significant 
delays seeking emergency care even when they present with oncological emergencies 
(Oatley et al., 2016; Szwajcer, Czaykowski, & Turner, 2011).   
The recognition of oncological emergencies is essential to establish the correct 
identification and prompt delivery of appropriate care (Iacobellis et al., 2018). It is the 
responsibility of the triage nurses to identify those patients correctly to ensure prompt 
assessment and treatment in the ED. In this paper, we have three main objectives. We first 
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review select oncological emergencies that are regularly treated in the ED and discuss the 
characteristics and outcomes of each. Febrile neutropenia (FN) is given a particular focus 
because it is the most common oncological emergency. Second, we conduct a critical 
evaluation of the effectiveness of the Canadian Emergency Department Triage and Acuity 
Scale (CTAS) in identifying the urgency of common oncological emergencies. Finally, 
we provide some recommendations for refining the CTAS guidelines and evidence-based 
strategies which, if implemented, would improve the ED care of oncological emergencies.   
Methods 
We used the Complaint Oriented Triage (COT 2012) - (English Canada Version 
02.02) to triage select oncological emergencies. The COT is an interactive computerized 
tool used in Canadian EDs to triage patients. This tool is based on the 2012 version of the 
Canadian Triage and Acuity Scale (CTAS 2012), Pediatric CTAS (Ped-CTAS 2012), and 
the Canadian Emergency Department Information System (CEDIS 2012) Chief 
Complaint list v2.0. It was established by the CTAS National Working Group and the 
Canadian Association of Emergency Physicians, by integrating the national CEDIS 
presenting complaint list with the CTAS modifiers. The COT Power point application can 
be freely downloaded from the Canadian Association of Emergency Physicians website. 
The first author evaluated the process of ED triage using the common manifestations of 
each oncological emergency. The purpose was to examine if these emergencies can be 
prioritized appropriately using the CTAS guidelines.  
  This COT tool is intuitive and can guide the triage decision through the triage 
assessment until the appropriate triage score is assigned to the patient. Triage assessment 
using this tool starts with age selection as the nurse can select between adult CTAS 
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(CTAS 2012) or pediatric CTAS (Ped-CTAS 2012). In the 2nd step, the nurse selects the 
chief complaint as described by the patient (Figure 1).  
 
 
Figure 1. Chief Complaint Selection 
Note. Screenshot from the COT application. The application can be freely downloaded from the Canadian Association of Emergency 
Physicians website at http://www.caep.ca/template.asp?id=B795164082374289BBD9C1C2BF4B8D32.  
 
For the demonstration, a triage nurse considered a patient with cancer who 
presented with fever. If a nurse selects “Fever” from the “General & Minor” icon or the 
temperature icon from the sidebar, the tool will transfer the nurse to a different screen as 
seen in Figure 2 and 3; respectively. From these screens, the nurse can see that patients 
who are immunocompromised with neutropenia (or suspected) are supposed to receive a 
triage score of 2 without the need for any further assessment. The guidelines define 
immunocompromised status as those with neutropenia (or suspected neutropenia) or on 
chemotherapy or immunosuppressive drugs including steroids (Bullard et al., 2017). 
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
 
63 
 
Figure 2. Triage of Fever 
Note. Screenshot from the COT application. The application can be freely downloaded from the Canadian Association of Emergency 
Physicians website at http://www.caep.ca/template.asp?id=B795164082374289BBD9C1C2BF4B8D32.  
 
 
Figure 3. First Order Modifiers 
Note. Screenshot from the COT application. The application can be freely downloaded from the Canadian Association of Emergency 
Physicians website at http://www.caep.ca/template.asp?id=B795164082374289BBD9C1C2BF4B8D32.  
 
Furthermore, the COT system guides the triage nurse to assign a triage score of 2 
to any immunocompromised patient regardless of their chief complaint, if this patient has 
a temperature at the time of triage. Complaints such as chest pain, hypertension, general 
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weakness, leg swelling, facial trauma, sore throat, facial pain, and even a complaint such 
as anorexia are considered as potentially indicative of sepsis (a complication of FN) if the 
patient has an increased temperature at triage (Figure 4). Similarly, we have applied the 
2012 COT in the triage of remaining oncological complaints and emergencies. In this 
article, however, we only report on four of the most life-threatening oncological 
emergencies including superior vena cava syndrome (SVCS), cardiac tamponade, tumor 
lysis syndrome (TLS), and febrile neutropenia (FN).
 
 
 
Figure 4. Other Chief Complaints 
Note. Screenshot from the COT application. The application can be freely downloaded from the Canadian Association of Emergency 
Physicians website at http://www.caep.ca/template.asp?id=B795164082374289BBD9C1C2BF4B8D32.  
 
The Urgency of the Oncological Complaints 
Although cancer is a chronic disease, patients with cancer can still experience 
acute emergencies, and therefore, be referred to the ED (Bosscher, Leeuwen, & Hoekstra, 
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
 
65 
2015; Brown et al., 2016; Sadik et al., 2014). The frequency of ED use among patients 
with cancer is considered high with many patients visiting the ED during chemotherapy 
treatment (Gorham et al., 2013; Oatley et al., 2016). Despite the frequency of visits, 
individuals with cancer represent a small minority when compared to the total number of 
emergency visitors. In a study on the characteristics of ED visits by patients with cancer, 
the number of visits by individuals with cancer ranged between two and six percent of all 
ED visits (Hsu et al., 2018). This small percentage of patients likely represents a 
challenge for triage nurses. In addition to the infrequency of presentation at the ED, 
individuals with cancer suffer from a wide variety of cancer diseases. This results in a 
broad range of disease-specific complications that adds to the challenge of accurately 
identifying severe health concerns. 
Other factors may also add to the complexity of effective triage of oncological 
emergencies. For example, cancer is dominant among the elderly population who are 
often affected by multiple comorbidities (Barnett et al., 2012). This may cloud the origin 
of the presenting problem. As well, ED visits were found to be more frequent among 
terminally ill cancer patients. Researchers of a study in Canada identified that individuals 
with cancer made the majority of ED visits in the last six months of life, with 83% 
visiting the ED within the last two weeks before death (Elsayem, Elzubeir, Brock, & 
Todd, 2016). Gorham and colleagues (2013) reported that patients with advanced and 
metastatic cancer comprised 95% of all cancer visits. It is possible, therefore, that some 
patients with cancer are misidentified by associating their ED visit with the need for 
palliative or hospice care. Acute complications are attributed to the dying process and do 
not get addressed appropriately (Tang et al., 2009). However, the findings of other studies 
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support that these presentations were true emergencies and were associated with severe 
complications (Delgado-Guay et al., 2015).  
Patel and colleagues (2015) explored the outcomes of telephone triage services 
designed to help individuals living with cancer manage their symptoms. Results indicated 
that 62% of individuals who made a call were referred to the ED. The urgency of 
oncological complaints is high; in one study, more than two-thirds of patients with these 
complaints reported to the ED (McKenzie et al., 2011). This is to be expected considering 
that patients usually require more ED resources such as radiologic imaging, invasive 
procedures, and medication administration (Hsu et al., 2018). 
The burden and consequences of these oncological complaints are also significant, 
resulting in considerable morbidities and mortality (Considine, Livingston, Bucknall, & 
Botti, 2009). Patients with cancer have a higher admission rate than that of the general 
ED population (Brown et al., 2016). Multiple studies reported an admission rate range of 
60 - 90% in patients with oncology-related ED visits compared to an admission rate range 
in the other adult ED patients of 13 - 46% (Bryant et al., 2015; Brown et al., 2016; 
Elsayem et al., 2016; Oatley et al., 2016). Cancer-related complaints were ten times more 
likely to result in admission compared to other ED patients (Meer et al., 2016). Cancer-
related admission accounts for 14% of total admissions from the ED (Fortun et al., 2004).   
As well, individuals with cancer have high readmission rates to the hospital which 
is indicative of the gap between needed versus provided care. Results from the Canadian 
Institute for Health Information (CIHI) indicated that oncological complaints were one of 
the top five conditions for readmission rate (CIHI, 2012). A study of patients with head 
and neck cancer reported 22% of patients were readmitted two to three times (Tang, 
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
 
67 
Cheng, Huang, Chang, & Chen, 2015). Patients with cancer can also experience a longer 
length of stay in the ED and hospital (five hours and nine days, respectively) (Hsu et al., 
2018). This is expected as oncological complaints have a higher level of acuity, which 
requires more intervention resulting in longer management time and length of stay in the 
ED and hospital (Meer et al., 2016). On average, patients stay in the hospital for nine days 
with 58% of the admissions staying more than one week.  
Furthermore, ED patients with oncological complaints are at higher risk for death 
than other ED patients. On average, between 10 - 12% of patients with cancer-related 
presentations die in the ED (Kotlinska-Lemieszek & Wyrwinska, 2014; Tang et al., 
2015). Results from a systematic review showed higher mortality rates (13 - 20%) among 
ED patients with oncological presentations (Vandyk et al., 2012). However, a lower 
mortality rate (1%) is noted in the general ED population (Dent, Rofe, & Sansom, 1999; 
Doherty, 2003). Emergency visits were also described as a predictor of poor survival 
among patients with cancer (Oatley et al., 2016). For instance, the one-year overall 
survival of all patients with cancer visiting ED was 7.3 months (Sadik et al., 2014). Other 
studies reported poorer survival rates in which half of the cancer patients passed away 
within three months of their visit to the ED (Bryant et al., 2015). Minami and colleagues 
(2013) documented much worse survival time with a median interval from ED visit to 
death of 49 days. 
The Nature of Oncological Complaints  
In the previous discussion, the high acuity experienced by individuals with cancer 
who seek emergency care was established. Most of these patients were admitted, 
experienced an extended LOS, and had increased mortality. However, by examining the 
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presenting complaints of those patients, it was found that they appeared simple with 
typical signs and symptoms such as pain, nausea and vomiting, weakness, dyspnea, and 
fever (Kao, Liu, Koo, & Chiang, 2018).  
The urgency of oncological complaints cannot be understood without examining 
the nature of the serious underlying problems causing these simple complaints. Although 
many presented with simple complaints, the underlying pathology was severe and 
resulted in a difficult-to-detect oncological emergency. Oncologic emergencies are 
described as complications of cancer or its treatment that become life-threatening or may 
lead to an irreversible disability (Samphao, Eremin, & Eremin, 2010). Oncological 
emergencies can be caused by the local effects of the primary tumor, metastasis to other 
organs, and complications from chemotherapy or other cancer treatment (Iacobellis et al., 
2018). Some oncologic emergencies are insidious; whereas, others manifest swiftly, 
causing devastating outcomes such as paralysis and death (Sadik et al., 2014). Therefore, 
in the next section, we review select oncological emergencies and examine the challenges 
of accurate triage decisions and the timely delivery of emergency care. 
Emergency Triage of Oncological Emergencies 
Oncological emergencies are known to be emergent and need to be identified 
expeditiously to allow for prompt treatment to minimize morbidity and mortality (Khan et 
al., 2017; Pi et al., 2016). Unfortunately, patients experiencing oncological emergencies 
are found to have longer-than-safe ED wait times even though they were suffering from 
severe conditions (Nirenberg, Mulhearn, Lin, & Larson, 2004; Oatley et al., 2016; 
Szwajcer et al., 2011). Still, EDs are designed to provide emergency care according to the 
clinical urgency of the health problem. For example, individuals with severe and life-
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threatening conditions are supposed to be assessed and treated first (Considine et al., 
2009). To achieve this objective, different triage systems were introduced worldwide to 
ensure the correct identification of patients’ health status, and therefore, provide care and 
treatment promptly.  
In Canada, the Canadian Triage and Acuity Scale (CTAS) guidelines are used to 
standardize triage decisions, making decisions more objective and justified (Bullard et al., 
2017). On arrival to the ED, the triage nurse uses the CTAS guidelines to categorize the 
patient’s health acuity into one of five categories. CTAS categories represent the level of 
urgency of the patient’s presenting health condition. Clinical decisions as to the 
appropriate CTAS category are based on how urgently the patient needs to be seen by the 
ED physician. Categories are determined by the time in minutes that an individual can 
safely wait before medical intervention. The five CTAS categories are: 1) resuscitation 
(immediate lifesaving treatment by both nurse and physician), 2) emergent (up to 15 
minutes to be seen by a physician), 3) urgent (between 15 and 30 minutes), 4) less-urgent 
(60 minutes), and 5) non-urgent (more than 120 minutes) (Beveridge et al., 1998). 
In this section, we will review the CTAS guidelines and evaluate if select 
oncological emergencies were appropriately identified in the guidelines. It is essential to 
examine whether such documented delayed emergency care could be attributed to an 
inherent limitation within the triage guidelines.  
Superior vena cava syndrome (SVCS). Many chemotherapeutic agents can 
cause cardiotoxicity and increase the risk for one of the cardiovascular oncological 
emergencies including SVCS and cardiac tamponade (Adelberg & Bishop, 2009). SVCS 
occurs when the venous circulation through the superior vena cava is obstructed. Tumor 
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expansion can compress the superior vena cava externally with metastasis (Kehoe, 2007). 
It is estimated that over 90% of cases of SVCS are attributed to malignancy (Wilson, 
Detterbeck, & Yahalom, 2007). Signs and symptoms of SVCS include dyspnea, non-
productive cough, hoarseness, dysphagia, facial swelling, visual disturbances, headache, 
and altered level of consciousness (Wilson et al., 2007). SVCS is an emergency requiring 
immediate treatment, but detection is difficult (McCurdy & Shanholtz, 2012). Because it 
develops gradually, SVCS is unlikely to present as a life-threatening condition (Samphao 
et al., 2010). Consequently, patients who present with no clear manifestations or present 
with non-severe manifestation such as cough, hoarseness, dysphagia, facial swelling, and 
visual disturbances may be triaged to the lower acuity level of ‘4’ or ‘5’. Under CTAS, 
patients with SVCS would only be triaged to the higher acuity level of ‘1’ or ‘2’ if they 
presented with severe symptoms such as altered level of consciousness. 
Cardiac tamponade. This life-threatening emergency is the result of pericardial 
effusion, which affects 20-34% of patients with cancer (Khan et al., 2017; McCurdy & 
Shanholtz, 2012). Excess fluid accumulates in the pericardial space, resulting in increased 
intrapericardial pressure. The pressure can compress the heart and decrease cardiac 
output, resulting in tamponade (Kehoe, 2007; Khan et al., 2017). Dyspnea is the 
presenting symptom for 80% of patients. Pulsus paradoxus (a decrease in blood pressure 
during inspiration) is another common sign that occurs in 30% of individuals with 
oncological pericardial effusion and 77% of those with acute tamponade (McCurdy & 
Shanholtz, 2012). Other symptoms can include chest pain, tachypnea, orthopnea, 
tachycardia, distended neck veins, dizziness, fatigue, and diaphoresis (Gabriel, 2012; 
Kehoe, 2007). Cardiac tamponade requires timely recognition to prevent rapid fatal 
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deterioration. The cardiac shock associated with tamponade is treated differently than 
traditional shocks as fluid resuscitation can be potentially detrimental, and patients 
usually require bedside emergency pericardiocentesis (McCurdy & Shanholtz, 2012). 
Cardiac tamponade patients present with complaints of cardiac decompensation and 
according to the CTAS guidelines, these patients should be triaged to an acuity level of 
‘2’. However, the gradual and chronic accumulation of fluids makes it unlikely to present 
with a life-threatening condition as the body adapts to these incremental changes. This 
makes cancer-related cardiac tamponade more severe as the patient can collapse quickly 
due to cardiogenic shock. Therefore, triage nurses must have prior knowledge and be 
critical in their examination of all cancer patients with cardiac manifestations to ensure 
the appropriate triage of this life-threatening oncological emergency. 
Tumor lysis syndrome (TLS). TLS is another vague oncological emergency. 
TLS can present insidiously but can be associated with significant morbidities and 
mortality if not recognized early and treated appropriately (Howard, Jones, & Pui, 2011; 
Muslimani et al., 2011). TLS is a metabolic emergency resulting from lysis of tumor cells 
leading to the release of tumor cellular contents into the systemic circulation (Cairo, 
Coiffier, Reiter, & Younes, 2010). The kidneys cannot compensate for the large volume 
of toxins that need to be filtered from the body (Kehoe, 2007). The subsequent metabolic 
abnormalities include hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia, 
and acute kidney injury. These metabolic abnormalities can lead to life-threatening 
manifestations such as cardiac dysrhythmias and neurologic complications (Namendys-
Silva et al., 2015).  
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TLS can occur spontaneously but is usually associated with the induction of 
chemotherapy or radiotherapy (Pi et al., 2016). However, all types of cancer treatment 
can cause TLS (Davidson et al., 2004). The clinical manifestations can include vague 
signs and symptoms such as diarrhea, lethargy, muscle cramps, nausea and vomiting, 
weakness, and oliguria (Kehoe, 2007). Diagnosis is dependent on the laboratory values 
including a complete blood cell count and a metabolic panel of liver and kidneys (Lyman, 
Abella, & Pettengell, 2014). Emergency management includes measures to reduce the 
risk of renal impairment and treatment of metabolic abnormalities with fluid resuscitation 
to increase excretion of the extra metabolites (Cairo et al., 2010; Coiffier, Altman, Pui, 
Younes, & Cairo, 2008). 
Tumor lysis syndrome can be hard to triage appropriately and a patient can 
receive less priority according to the CTAS guidelines. Patients can earn a higher triage 
acuity score if they present with fatal cardiac arrhythmias, but early detection at triage is 
unlikely because an ECG is required, and this is not usually performed during triage 
assessment. Delayed identification can have severe, life-threatening complications with 
significant morbidities and mortality as previous reports support (Howard et al., 2011; 
Muslimani et al., 2011).  
Febrile Neutropenia (FN). Bone marrow suppression is an expected side effect 
for many of the chemotherapeutic regimens, and specifically, neutropenia is the most 
profound clinical consequence. All chemotherapeutic drugs have a cytotoxic effect and 
are capable of inducing neutropenia to various degrees (Adelberg & Bishop, 2009). Fever 
and infection secondary to neutropenia are the most severe, life-threatening complications 
of cancer treatment and are a significant cause of hospitalization and death (Bryant et al., 
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2015; Kuderer, Dale, Crawford, Cosler, & Lyman, 2006). Patients with cancer are four 
times more likely to present with severe sepsis from neutropenia compared with non-
cancer patients (2.1% vs. 0.5%) (Hsu et al., 2018). Cancer patients have double the risk of 
mortality if presenting with sepsis at the ED as they may be experiencing a subtle but 
severe underlying infection (Prachanukool, Tangkulpanich, Paosaree, Sawanyawisuth, & 
Sitthichanbuncha, 2016).  
Fever is one of the most common reasons for ED visits among patients with 
cancer (Vandyk et al., 2012). Fever may be the only presentation for FN, but many 
patients are afebrile (Freifeld et al., 2011). Fever as a cancer-related ED presentation is 
likely to be associated with neutropenia (45%), sepsis (26%), and pneumonia (14%). 
Reports of ED care of patients with fever demonstrated the urgency of this complaint as 
more than 83% of patients with fever were admitted to the hospital (Sadik et al., 2014; 
Vandyk et al., 2012). Emergency admissions of cancer patients were found to be 
significantly associated with the complaint of fever (Tanaka et al., 2017). Not all 
neutropenic patients will present with a fever, nor does all fever indicate febrile 
neutropenia (FN). However, all cancer patients presenting to ED should be queried for 
FN until ruled out with proper examination (Adelberg & Bishop, 2009).  
The risk of FN with chemotherapy is about 17%, and the risk rises with repeated 
chemotherapy cycles (Oatley et al., 2016; Weycker, Barron, Kartashov, Legg, & Lyman, 
2014). Others reported a higher rate of FN occurring in half of the patients receiving 
chemotherapy (Hashiguchi et al., 2015). FN may result in significant clinical implications 
such as delaying and discontinuing chemotherapy and is associated with considerable 
morbidity, mortality, and costs (Lyman et al., 2014). One study documented the burden of 
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hospitalized FN in relation to hospital mortality (14%), length of stay (13 days), and costs 
($22,800) (Kuderer et al., 2006). FN is the cause of death in 4% to 30% of patients with 
cancer (Talcott, Finberg, Mayer, & Goldman, 1998). Empiric antibiotics should be 
initiated promptly as delayed initiation of antibiotics can be associated with increased 
mortality due to rapid progression to septicemia (Adelberg & Bishop, 2009; Lim et al., 
2011; Livingston, Craike, & Slavin, 2012; Meer et al., 2016). 
The CTAS guidelines do identify the urgency of FN but only if the patient has a 
high fever at triage. The guidelines recommend the assignment of a triage rating of ‘2’ if 
the patient has a fever and is immunocompromised or is receiving chemotherapy 
treatment (Beveridge et al., 1998). Moreover, fever in FN is defined as “a low neutrophil 
count of 1.5 × 109 /L and single oral temperature measurement of > 38.3°C or a 
temperature of > 38.0°C sustained over one-hour period” (Freifeld et al., 2011, p. e61). 
Nirenberg et al. (2004) found that the majority of FN patients experienced fever for a 
mean time of 21 hours before seeking emergency care. However, patients may not have a 
fever when presenting at triage which renders them to be assigned to a less urgent triage 
category.  
In reviewing studies examining triage implementation among patients with 
oncological emergencies, findings confirmed that this patient population was more likely 
to be assigned a lower acuity triage score. For example, an Australian ED study of newly 
diagnosed patients with cancer receiving chemotherapy showed that 79% of patients were 
assigned an acuity rating that was lower than recommended by the Australian Triage 
Scale guidelines (Livingston et al., 2011). Similarly, a Canadian study of patients with 
emergency-related oncological complaints demonstrated that two-thirds of patients were 
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assigned to lower triage acuity ratings (less urgent) (Barbera et al., 2012). Furthermore, 
cancer patients and their families perceived that their oncological presentations were not 
given accurate ratings at triage (Ekwall, Gerdtz, & Manias, 2008). These perceptions 
were accurate as patients have been inappropriately delayed in receiving needed care 
(Nirenberg et al., 2004; Oatley et al., 2016; Szwajcer et al., 2011). 
The standard of care is to treat FN as an oncologic emergency; patients are 
expected to be seen right away to commence prompt delivery of the necessary treatment 
(Lim et al., 2011). Although fever is an essential sign of infection, lack of fever does not 
necessarily exclude it (Adelberg & Bishop, 2009). The FN clinical guidelines recommend 
that afebrile neutropenic patients who have new signs or symptoms suggestive of 
infection to be evaluated and treated as high-risk patients (Freifeld et al., 2011). 
Furthermore, the presence of fever does not guarantee proper triage. For instance, an 
Australian study of 200 neutropenic episodes illustrated that 1/3 of patients were 
inappropriately assigned to the less urgent triage category to be seen in a time that is far 
longer than what is considered clinically appropriate (Livingston et al., 2012). A study of 
ED oncological complaints reported that the deceased group of patients were more likely 
to have been triaged to less urgent categories where they witnessed longer wait times and 
ED length of stay (Livingston et al., 2012). For patients with FN, timely care is very 
important as the time to initiation of effective antimicrobial therapy is the most reliable 
predictor of outcome among patients with early signs of sepsis, with around 8% drop in 
their survival for every hour of delay (Kumar et al., 2006). The CTAS guidelines allow 
for prompt treatment of patients with fever. The recommendations are to allocate those 
patients into the second acuity triage rating, enabling them to be seen by a physician 
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within 15 minutes. However, not all FN patients have a fever at triage, meaning a lower 
rating is allocated; patients often experience significant delays. Furthermore, the 
implementation of the CTAS seems inappropriate in most of the occasions where two-
thirds of patients with FN who had a fever at triage were allocated to a lower than 
appropriate triage acuity rating. 
Discussion 
The ED remains an accessible place to receive timely treatment with the 
availability of multiple and comprehensive laboratory and radiological examinations and 
a provision of coordinated and multidisciplinary care that is adequate for the complex 
conditions of those patients (Numico et al., 2015). However, with large volumes of 
patients and periodic overcrowding, the accuracy of ED triage becomes more critical as 
inaccurate triage can result in longer delays (Bryant et al., 2015). Timely treatment of 
oncology patients in the ED can dramatically enhance their quality of life and improve 
their survival (Mofid, Novin, Roointan, & Forouzanfar, 2016). ED health professionals, 
and especially triage nurses as the gatekeepers of emergency care, should have a strong 
knowledge base regarding oncological emergencies and be thorough in their examination 
of patients with these conditions (Samphao et al., 2010). Oncologic emergencies may be 
insidious and may have rapidly deleterious effects (Wagner & Arora, 2017). Knowledge 
of the signs and symptoms of these emergencies will enable triage nurses to accurately 
differentiate the urgency of the different presenting complaints (Diaz-Couselo et al., 
2004). Education that prepares triage nurses to better understand the complexity of the 
symptom presentation and the needed care for patients with different oncological 
emergencies is essential (Grol et al., 2013). There is strong evidence that adequate 
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knowledge is the most crucial element in making accurate triage decisions (Considine, 
Botti, & Thomas, 2007; Smith et al., 2013). Knowledgeable health providers, in 
partnership with patients and families who are well-informed about the risks and 
complications of oncological emergencies, can ensure the best care possible.  
The review of the CTAS guidelines has identified some limitations concerning 
clear guidance for triage nurses. Although revisions have been implemented and the 
reliability of the CTAS tool has improved, the guidelines are designed to be generic and 
cannot address every health situation (Bullard et al., 2008). Febrile neutropenia is an 
excellent example of the additional supports needed at triage to accurately determine the 
patient’s health status. The FN clinical guidelines, for example, identify afebrile 
neutropenic patients as high-risk (Freifeld et al., 2011), demonstrated by a significantly 
higher 30-day in-hospital mortality (Strojnik et al., 2016). Accordingly, the CTAS 
guidelines must be updated to reflect such up-to-date evidence. Point of care testing at 
triage can enable the early recognition of neutropenia and prevent any inappropriate delay 
among afebrile neutropenia patients. 
Also, triage nurses need to be well informed about and convinced by the scientific 
evidence in order to follow the guidelines more closely (Grol et al., 2013). Some studies 
highlighted discrepancies in triaging cancer patients even when they present with FN 
(Howlett and Atkinson, 2012; Nirenberg et al., 2004; Oatley et al., 2015; Szwajcer et al., 
2011). A similar discrepancy was evident among acute myocardial infarction patients 
(Atzema et al., 2009). Education strategies should address the need to objectify the 
triage process and to promote skill and ease in those using the guidelines. This 
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specific recommendation was made by the establishers of the CTAS guidelines, that 
is, to properly use and implement the CTAS guidelines in order to make an accurate 
assignment of triage levels (Bullard et al., 2008). Such a desire for objectivity in 
triaging patients has led to the development of a computerized version of emergency 
triage (e-CTAS) (Dong et al., 2006). However, we used a similar version to this e-
CTAS using the 2012 complaint-oriented triage (COT), but we failed to prioritize the 
urgency of these oncological emergencies using this tool.  
Other strategies to improve recognition of oncological emergencies were also 
found helpful such as the implementation of fever alert cards (FACs). Kapil et al. (2016) 
evaluated FACs as a communication tool to decrease TTA in patients with FN who 
present to the ED. The implementation of FACs helped in improving FN recognition with 
a higher percentage of patients obtaining a correct CTAS score. This can be combined 
with clinical protocols and pathways to fast-track patients with certain conditions. For 
example, the Febrile Neutropenia Pathway (FNP) was introduced to one ED and was 
found helpful in reducing time to antibiotics by almost two thirds (Keng et al., 2015). 
However, we could not allocate similar strategies to improve recognition or timely 
treatment in the ED for other oncological emergencies described earlier. Finally, EDs 
should follow the CTAS guidelines recommendations in monitoring the time objectives 
set by the guidelines and tailor their resources to meet these benchmarks (Bullard et al., 
2008). Routine system monitoring and benchmark analysis of wait times for patients in 
different categories can be considered necessary. However, studies with such main 
objective are of rarity or can be underreported.  
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Conclusion 
In this paper, we reviewed the underlying reasons for patients with cancer to seek 
emergency care. We demonstrated that these ED presentations and subsequent 
hospitalizations are a necessary service for individuals with cancer and are not avoidable. 
Patients with cancer have a higher acuity compared to many other ED patients and they 
experience high rates of hospital admission and increased risk of death. However, most 
cancer patients suffer significant delays when seeking emergency care even when they 
presented with oncological emergencies. Many of these emergencies have time-sensitive 
interventions, making it crucial to establish the correct identification at triage to enable 
the prompt delivery of appropriate care. Because many of these complaints can be subtle 
and nonspecific accurate identification often takes time. This poses risk to those 
experiencing oncological emergencies and suggests that the CTAS guidelines need to be 
strengthened to better represent the urgency of these life-threatening conditions. 
Based on our review, we suggested a couple of refinements to the guidelines to 
increase their sensitivity in detecting oncological emergencies. Also, strategies were 
identified to improve compliance in using the guidelines. We emphasized the role played 
by education to prepare the patients, families, and the triage nurses to better understand 
the complexity of oncological emergencies, their signs and symptoms, and the needed 
emergency care. Finally, routine system monitoring and benchmarks analysis were 
highlighted as one approach to meet the time objectives set by the guidelines. 
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The Quality of Care in the Emergency Management of Cancer Patients with Febrile 
Neutropenia 
 
 
Chapter Three 
 
 
This chapter constitutes the second manuscript of the thesis. In this manuscript, the aim 
was to evaluate the ED quality of care for patients with FN in terms of the four quality 
dimensions: safety, effectiveness, patient-centeredness, and timeliness of care.  
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Abstract 
Background: Febrile neutropenia (FN) is one of the most severe oncological emergencies 
associated with the treatment of cancer. Patients with FN are at a grave risk of developing 
life-threatening sepsis unless there is rapid initiation of treatment.  
Purpose: To evaluate the quality of ED care of patients with FN using the four quality 
dimensions of safety, effectiveness, patient-centeredness, and timeliness of care.  
Methods: A retrospective review of all available records of adult cancer patients with FN 
who presented to one urban ED in Atlantic Canada was conducted over five years.   
Results: Examining twelve quality indicators of the 431 patients included in the study 
identified areas for improvement in each of the four dimensions. Over one-third of the 
participants were unsafely discharged from the ED despite the severity of their condition. 
The vast majority were not prescribed a growth factor at the initiation of cancer treatment, 
a prevention strategy for the development of FN, and were not provided a prescription 
during their ED visit. Pain assessment and management were not prioritized during the 
ED experience. Patients in the study were not seen promptly by the physician, and did not 
receive timely treatment during different phases of their visit. Most importantly, the delay 
in antibiotic administration presented a major risk for this population. 
Conclusion: Aspects of care provided to this cohort of FN patients were inconsistent with 
the recommended evidence. Strengthening ED care is necessary to reduce the gap 
between evidence-based and actual care. Quality initiatives can be implemented to 
improve care to become safer, effective, patient-centered, and timely. Nurses who are in 
direct contact with the patients and who are actively involved in every single process of 
the health care system are well positioned to lead this change. 
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Febrile neutropenia (FN) is the most common side effect related to cancer 
treatment (Bryant et al., 2015). FN is a potentially life-threatening condition as patients 
can suffer a profound bone marrow suppression leaving them susceptible to severe 
infections (Weycker et al., 2016). Infection due to neutropenia is associated with 
significant morbidity and mortality in patients receiving chemotherapy (Meer et al., 2016; 
Walji et al., 2008 ; Weycker et al., 2016). For example, FN is a predisposing factor for 
sepsis, and therefore, prevention of FN is a crucial strategy to reduce the disease burden 
(Paddock, Grock, Deloughery, & Mason, 2017). Evidence-based strategies have been 
promoted to minimize the occurrence of FN, particularly the use of growth factors and 
prophylactic antibiotics (Ganti, Marini, Nagel, Bixby, & Perissinotti, 2017; Taplitz et al., 
2018). Administration of growth factors such as Filgrastim (G-CSF) has been associated 
with a lower incidence of FN (Kawatkar et al., 2017). However, despite this benefit, their 
use is limited, which likely impacts the number of patients experiencing FN (Andre et al., 
2010; Szwajcer, Czaykowski, & Turner, 2011).  
The emergency department (ED) remains an accessible place for patients with FN 
to receive timely treatment, and until more focus is given to prevention of this 
complication, it should be anticipated by the ED (Kawatkar et al., 2017; Numico et al., 
2015). The standard of care is for individuals with FN to be seen by the ED physician 
within 15 minutes of triage (Bullard et al., 2017) and to commence antibiotics within one 
hour (Freifeld et al., 2011). The time to initiation of effective antimicrobial therapy was 
reported as the single most reliable predictor of outcome among patients with early signs 
of sepsis (Kumar et al., 2006).  
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Delayed ED care and increased wait times are associated with adverse outcomes 
among patients with FN (Keng et al., 2015; Klastersky, 2004; Koh & Pizzo, 2002), while 
earlier administration of antibiotics is associated with fewer complications in terms of 
infection, sepsis, and prolonged LOS (Lynn et al., 2013). Morneau et al. (2017) found that 
each hour of delay in the administration of antibiotic therapy increased the odds of in-
hospital mortality by 16%, while earlier management significantly reduced the mortality 
odds by 33% (Johnston et al., 2017). However, delayed emergency care and prolonged 
time to antibiotics have been reported in a number of epidemiological studies where 
antibiotics were administered from 3.5 – 5.0 hours after ED presentation (Nirenberg, 
Mulhearn, Lin, & Larson, 2004; Oatley, Fry, & Mullen, 2016; Szwajcer et al., 2011).  
The aim of this study was to evaluate the quality of ED care of patients with FN in 
terms of four quality dimensions: safety, effectiveness, patient-centeredness, and 
timeliness of care. The other two quality dimensions (efficiency and equity) were not 
examined. In particular, we were interested in whether patients were treated according to 
the benchmarked time for treatment as specified in the triage and FN guidelines. Limited 
information is available to determine if appropriate and timely emergency care is 
provided for this vulnerable population. Previous studies were limited to the examination 
of the benchmarked time for the administration of antibiotics only. This study has taken a 
broader perspective that includes observations on several dimensions of quality within the 
ED and, to a lesser degree, observations on some aspects of primary care known to 
prevent the occurrence of FN. This evaluation can inform the adoption of evidence-based 
policies to enhance the efficiency and effectiveness of ED processes for more positive 
patient outcomes.  
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
 
96 
Methods 
The research design was a retrospective review of available records of adult 
cancer patients undergoing active treatment for cancer. The targeted population included 
all cancer patients in the provincial cancer registry with a first presentation of fever to one 
ED occurring on a date after the time of their cancer diagnosis. The provincial cancer 
registry contains information on all individuals diagnosed with cancer in the province and 
is maintained by the provincial cancer program. Patients were included in the study if 
they were: i) at least 18 years old, ii) undergoing active cancer treatment, and ii) came to 
the ED with a presentation of fever between April 1, 2011, and March 31, 2016. Patient 
data from the cancer registry were directly and securely transferred to the province’s 
health information agency. There, the registry data were linked with the identified 
hospital’s ED patient information system using the inclusion criteria. After the data 
linkage, 444 patient health records were provided to the researchers. A review of the files 
identified 13 that were ineligible as the presenting complaint at the ED was not related to 
fever. The sample was sufficient according to the prior sample size calculation. To 
facilitate accurate data collection from the patient health record, the first author engaged 
in a two-week, informal orientation to the study setting to observe and understand the 
context and flow of care in the ED. These observations also helped understand the 
language and the abbreviations that were documented in the patient health records. 
Data were collected by conducting chart reviews using a standardized chart 
review form (CRF). A pilot test of the CRF was performed, and changes were made as 
necessary to enhance the rigor and minimize biases. For example, items on the CRF were 
rearranged to match the arrangement of data in the patient health records. As well, a 
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random selection of 176 cases (40% of the sample) was checked to ensure proper data 
coding and entry. Patients were assigned a unique study code to protect the confidentiality 
of their information. The provincial Health Research Ethics Board approved the study. 
Measures 
The ED quality of care was evaluated in terms of four quality dimensions: safety, 
effectiveness, patient-centeredness, and timeliness of care. These domains were 
operationalized using twelve measures. There is national consensus on the use of these 
measures, which are included as part of the Canadian ED national benchmarks (Schull et 
al., 2010).  
Safety. The first domain, safety, was measured by three variables: i) the frequency 
of patients who left without being seen (LWBS), ii) time to triage reassessment while 
waiting to be seen, and iii) appropriate ED disposition based on stratification of the 
severity of FN using the Multinational Association for Supportive Care in Cancer 
(MASCC) score as per the FN guidelines (Coyne et al., 2017). The MASCC score is used 
to assess the seriousness of FN and inform a decision about patient discharge. The 
calculated MASCC score categorizes patients with FN into low and high-risk based on a 
scoring system. Low-risk FN patients (MASCC score of ≥ 21) are considered stable and 
eligible for outpatient management with oral antibiotics (Paddock et al., 2017). High-risk 
patients should be admitted to the hospital with an immediate IV broad-spectrum 
antibiotic administered in the ED. Table 1 summarizes the MASCC criteria used to 
calculate the severity of FN. We rated each patient based on these criteria to decide on the 
appropriate disposition of patients from the ED. 
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Table 1 
MASCC Scoring System 
Characteristic Score 
The burden of FN with no or mild symptoms 5 
No hypotension (i.e., systolic blood pressure > 90 mmHg) 5 
No chronic obstructive pulmonary disease 4 
Solid tumor or hematologic malignancy with no previous fungal infection 4 
No dehydration requiring parenteral fluids 3 
Outpatient status 3 
Age < 60 years  2 
Note. Reprinted from “Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of 
Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update,” by Taplitz, R., Kennedy, E., Bow, 
E., Crews, J., Gleason, C., Hawley, D., . . . Flowers, C. (2018). Outpatient Management of Fever and Neutropenia in Adults Treated 
for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline 
Update. Journal of Clinical Oncology, 36(14), 1443-1453. Copyright 2018 by “American Society of Clinical Oncology.” 
 
Effectiveness. The effectiveness of care was the second domain and was 
evaluated by two measures. First, the risk of FN can be lowered with the appropriate use 
of preventive strategies such as the prescribing of growth factors for patients when they 
are receiving active cancer treatment. Second, the Fractile Response Rate (FRR) was used 
to assess the proportion of patients in each triage level seen within the guidelines’ time 
objective. The guidelines recommend that 95% of patients with FN be seen within 15 
minutes (be assigned a triage score of 2).  
Patient-centeredness. The third dimension was patient-centeredness, which was 
evaluated in terms of proper pain assessment and management in the ED.  
Timeliness. The final dimension, timeliness, was evaluated by five variables: time 
to physician initial assessment (PIA), ii) time to antibiotics (TTA), iii) sorting time, iv) 
boarding time, and v) ED length of stay (LOS). Operational definitions of these measures 
are provided in Table 2. 
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Table 2 
Operational Definitions of the Study Variables 
Quality 
Dimension 
Measures of the Quality 
Dimension 
Measurement 
Safety 1. Left without being 
seen. 
ED patients who leave the ED on their own without 
proper discharge by the ED physician or nurse. 
2. Time to Reassessment 
at Triage. 
The time from initial assessment at triage to the 
secondary assessment at triage when the observed 
wait time has passed the expected wait time.  
3. ED disposition. The final destination in the ED. Patients can be 
admitted, discharged, or be deceased. 
Effectiveness 4. Prescription of Growth 
Factors. 
The administration of growth factors such as 
Filgrastim (G-CSF) in the ED or before the ED visit. 
5. Fractile Response 
Rate. 
The proportions of patients in each triage level seen 
by a physician within the CTAS time objective for 
that level. 
Patient-
Centeredness 
6. Pain assessment. The assessment of pain during the first assessment at 
triage.  
7. Pain management. The administration of analgesia during the ED visit. 
Timeliness  8. Physician initial 
assessment (PIA). 
The time from ED triage assessment to the time to be 
seen by an ED physician. 
9. Time to antibiotics 
(TTA). 
The time from ED triage assessment to the time of the 
administration of antibiotics. 
10. Sorting Time. The time from ED triage assessment until the decision 
on admission or discharge is made. 
11. Boarding time. The time spent in the ED after the decision to admit 
until a hospital bed became available. 
 12. ED length of stay. The total time spent in the ED from ED triage 
assessment until the patient leaves the department. 
Note. These quality measures are considered evidence-based quality of care indicators and are included in the 
Canadian Emergency Department national benchmarks (Bullard et al., 2017; Freifeld et al., 2011; Health Quality 
Ontario, 2016; Kelly et al., 2014; Schull et al., 2010; Taplitz et al., 2018). The indicators were categorized based on 
the dimensions defined by the Institute of Medicine (2003). 
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Data Analysis 
We used one sample t-test to examine the observed vs. the expected PIA, TTA, 
and ED length of stay among admitted and discharged patients (15 minutes, 60 minutes, 
and four and eight hours for admitted and discharged, respectively). The remaining 
variables were analyzed and summarized using descriptive statistics. The analysis was 
done using the SAS software (version 9.4; SAS Institute Inc., Cary, NC, USA). 
Results 
Characteristics of Patients 
We identified 431 oncology patients from the provincial cancer registry who 
presented to one ED in Atlantic Canada with an episode of FN over the study period. 
About half of patients (51.5 %) were male with a mean age of 60 years (Range = 20-91). 
Most of the visits (56.0%) occurred during the evening hours (15:00H to 22:59H) with 
13.0% arriving by ambulance. The majority of patients (68%) were diagnosed with solid 
tumor and two-thirds had advanced malignancy (stage III or VI). Table 3 shows the 
patient demographics and their cancer characteristics. 
Table 3 
Patient Demographics and Cancer Characteristics 
Characteristic n (%) 
Sex             
Female 
Male 
 
209 (48.5) 
222 (51.5) 
Age    
< 60 yrs. 
        60-70 yrs. 
        >70 yrs. 
 
174 (40.0) 
158 (37.0) 
99 (23.0) 
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Results of the Quality Care Measures 
This quality evaluation provided evidence of needed improvements in the four 
quality dimensions: safety, effectiveness, patient-centeredness, and timeliness of care.  
Safety. Examining the three indicators within the domain of safety identified a 
small number of patients who left the ED after triage, but before being seen by the 
physician. Six patients (1.4%) left the ED without being seen (LWBS). In addition, the 
vast majority of the patients who waited at triage were not reassessed by the triage nurse 
at the intervals recommended in the CTAS guidelines. The seven patients (1.6%) who had 
a documented triage reassessment in their ED record waited an average of 98 minutes 
before being reassessed. Results for the safety indicators are summarized in Table 4. 
The final safety indicator, disposition, revealed that 154 patients (36%) were 
discharged home. Of note, were the 53 (34%) high-risk patients who went home in 
violation of the guidelines as the seriousness of their condition is considered too risky for 
Arrival Time    
                    Day  
                 Evening  
                   Night 
 
110 (25.0) 
240 (56.0) 
81 (19.0) 
Day of Arrival 
                Weekdays 
                Weekend 
 
293 (68.0) 
138 (32.0) 
Arrival Mode 
       Walk-In 
     Ambulance 
 
374 (87.0) 
57 (13.0) 
Type of Cancer 
 Solid 
   Hematological 
 
293 (68.0) 
138 (32.0) 
Cancer stage                                    
1+2 
               3 
             4 
 
121 (37.0) 
99 (31.0) 
104 (32.0) 
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outpatient management. A small number of discharged patients (n = 7, 5%) were found to 
suffer profound neutropenia with an absolute neutrophil count (ANC) of less than 500.  
Table 4 
Descriptive Results for Indicators in Three Quality Domains 
SAFETY DOMAIN n % EFFECTIVENESS 
DOMAIN 
n % 
Indicator Indicator 
1] Left without being seen 6 1.4 1] Growth factor  26 6.0 
2] Reassessment at triage 
     (Mean = 98 M). 
7 1.6 2] Fractile response rate     
3] Disposition: CTAS level of 2 (15 M)  17 10.8 
Admitted 271 64.0 CTAS level of 3 (30 M) 27 10.5 
 Low-Risk FN (MASCC ≥ 21) 31 11.4 Distribution of CTAS scores 
Discharged 154 36.0     Level 1: Resuscitation                1 0.2 
 High-Risk FN (MASCC < 21) 53 34 Level 2: Emergent  158 36.7 
 ANC < 500 7 4.5 Level 3: Urgent  258 59.9 
Profound & High-Risk FN with 
No Antibiotics 
5 3.3 Level 4: Less-Urgent  13 3 
PATIENT CENTEREDNESS Level 5: Non-Urgent  1 0.2 
Indicator Note. MASCC = Multinational Association for 
Supportive Care in Cancer; ANC = Absolute 
Neutrophil Count; CTAS = Canadian Triage 
and Acuity Scale; M = Minutes 
1] Pain Manifestations 38 9.0 
2] Pain assessment at triage  4 1.0 
3] Administration of analgesic 
     (Mean = 228 M) 
39 9.0 
 
Effectiveness. Results for the effectiveness indicators are summarized in Table 4. 
Two indicators were measured under this quality domain. One, the taking of growth 
factors while under active cancer treatment, is a preventive measure against the 
development of FN. Only 6% of study participants received the growth factor, Filgrastim 
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
 
103 
(G-CSF), prior to their presentation to the ED and no patients were started on G-CSF in 
the ED. The second effectiveness indicator was the fractile response rate (FRR) of triage 
implementation, which is an indication of how well the organization is meeting the time 
objectives of the CTAS guidelines. Only 11% of patients in both triage categories of two 
and three were seen by a physician in a time that was consistent with the CTAS 
recommendations. 
Patient-centeredness.  Pain assessment at triage was documented in only four 
patients (1.0%), but 38 patients (9.0%) presented with pain and 39 patients (9.0%) 
received opioids such as morphine at some point during their ED visit. The mean time to 
the administration of analgesia was 228 minutes. Patient-centeredness indicators are 
summarized in Table 4.  
Timeliness of Care. Five, time-sensitive indicators were measured to assess if 
patients with FN received the appropriate ED treatment that was responsive to their 
potentially life-threatening condition. The time from triage to the physician’s initial 
assessment (PIA) is a critical indicator in the timely initiation of required treatment. In the 
ED, the mean waiting time from triage to PIA was 81 minutes, which is significantly 
longer than the benchmark of 15 minutes (p = .001). On average, patients had to wait for 
228 minutes before the administration of antibiotics, which is significantly longer than the 
benchmark 60 minutes (p = .001). Only 4.0% of the patients in our sample received 
antibiotics within the time frame of one-hour as recommended in the guidelines. On 
average, it took more than 5.4 hours (SD = 3.2) for the health care team to decide on 
admission or discharge (sorting time). After the decision was made to admit the patient, 
there was an average wait time of 10.6 hours in the ED before being moved to an 
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inpatient bed. Among the admitted patients, the mean ED LOS was 21.9 hours (SD = 
15.1), which is significantly longer than the benchmark of eight hours (p = .001). Among 
the discharged patients, the mean ED LOS was 4.4 hours (SD = 2.6), which is 
significantly longer than the benchmark of four hours (p = .026). Treatment times of the 
FN patients are summarized in Table 5. Results from the one sample t-test are reported in 
Table 6. 
Table 5 
Descriptive Results for Indicators in the Quality Domain of Timeliness 
 
 
Event 
 
 
Mean 
(SD) 
 
 
Median 
(IQR) 
 
Percentiles 
 
5% 
 
25% 
 
50% 
 
75% 
 
90% 
Minutes Until Physician 
Initial Assessment (PIA) 
81.0 
(69.6)  
60.0  
(67.0) 
15.0 37.0 60.0 104.0 158.0 
Minutes Until 
Administration of 
Antibiotics (TTA) 
228.0 
(189.0) 
175.0 
(158.0) 
63.0 116.0 175.0 274.0 458.0 
Hours Until Decision for 
Admission or Discharge 
(Sorting Time) 
5.4 
(3.2) 
4.7  
(2.9) 
2.0 3.5 4.7 6.5 8.6 
Boarding Time (hrs) 10.6 
(14.2)  
3.7  
(17.3) 
0.0 0.1 3.7 17.4 27.0 
Admitted Patients ED 
LOS (hrs) 
21.9 
(15.1)  
19.3 
(18.0) 
5.1 9.8 19.3 27.8 43.8 
Discharged Patients ED 
LOS (hrs) 
4.4 
(2.6) 
3.9 
(2.1) 
1.8 2.9 3.9 5.1 6.7 
Note. The right side of the table illustrates the proportions of patients treated according to the 
benchmarks. For example, the cross-tabulation between the third column and the first row gives the 
proportion of patients who have met the CTAS guidelines benchmark for PIA (e.g., only 5% were seen 
by physician within 15 minutes as recommended by the guidelines). The last column (90th percentile) 
illustrates the maximum amount of time within which nine out of 10 patients were seen by the ED 
physician. 
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
 
105 
 
Table 6 
Comparison Between the Observed vs. Expected Treatment Time Using one sample t-test 
Test Value PIA = 15 minutes 
 Test Value TTA = 60 minutes 
                  Test Value Admitted ED LOS = 8 hours 
                     Test Value Discharged ED LOS = 4 hours 
  
 
 
t 
 
 
 
df 
 
 
 
Sig (2-
tailed) 
 
 
Mean 
Difference 
95% Confidence 
Interval of the 
Difference 
lower Upper 
PIA (minutes) 19.535 424 .001 66.0 59.36 72.64 
TTA (minutes) 16.173 333 .001 167.539 147.16 187.92 
Admitted Patients ED LOS (hrs) 15.139 270 .001 13.945 12.132 15.759 
Discharged Patients ED LOS (hrs) 2.241 153 .026 .471 .055 .886 
 
Discussion 
The Institute of Medicine of America (IOM) published a report in 2000 titled “To 
Err is Human” highlighting many safety and quality problems with current health care 
practices (Berwick, 2014; Kohn, Corrigan, Donaldson, & ProQuest, 2000). Similarly, the 
“Canadian Adverse Events Study” reported that 13.5% of the 2.5 million annual hospital 
admissions in Canada involved at least one adverse event with one in five patients 
experiencing permanent disability or death (Baker et al., 2004). These reports demystified 
the concept of quality of care as taken for granted, re-centering the focus on patient safety 
and demanded a redesign of the healthcare system to improve quality and safety (Kelly et 
al., 2014). In this study, we evaluated the quality of care on four of the six dimensions of 
quality according to the Institute of Medicine to include safety, effectiveness, efficiency, 
equity, patient-centeredness, and timeliness of care. 
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The Safety of Care 
Safety was operationalized by measuring three indicators. The frequency of 
patients who left without being seen (LWBS) was 1.4% which represents the proportion 
of patients with a failed attempt to access the ED. Previous studies suggest that a rate of 
less than 5.0% for patients who LWBS is deemed to be safe for patients with a low acuity 
rating (Ding et al., 2006). Nevertheless, this cannot apply to patients with FN as delayed 
emergency care is associated with severe adverse consequences (Keng et al., 2015). FN 
patients cannot afford not to receive emergency care; this rate should be zero for the 
safety of FN patients. 
Another indicator of potentially unsafe care is the absence of reassessment while 
waiting at triage. This evaluation is part of the triage process because the patients are 
expected to be continuously monitored until their initial assessment. Only seven patients 
(1.6%) had documentation in their ED record that they were reassessed while waiting at 
triage. This contradicts the triage guidelines because re-evaluation of patients who are 
waiting is necessary to ensure that their status is stable and their waiting remains safe. 
Moreover, the small number who were reassessed did not meet the recommended time for 
reassessment.  
Finally, safety was evaluated by the appropriate ED disposition after stratification 
of the severity of FN. The standard of care for patients with FN is to be admitted for 
protective isolation for prophylactic antibiotics until neutropenia is resolved (Weycker et 
al., 2014). Accumulated evidence suggests that the ED visits by individuals with FN are 
both unavoidable, and necessary, as seen by the majority of patients being urgently 
admitted (Nirenberg et al., 2004; Oatley et al., 2016). However, some patients can be 
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considered for initial management of FN in the ED with the possibility of discharge if 
certain conditions were met. In our sample of patients with FN, 36.0% were discharged 
home but over half of those discharged (59.0%) did not receive antibiotics in the ED. Of 
note, were the 53 (34%) high-risk, discharged patients who were not eligible for 
outpatient management based on the guidelines (Paddock et al., 2017). Also, seven 
patients (4.5%) of those high-risk discharged patients were found to suffer from a 
profound neutropenia with ANC of less than 500. Among the high-risk discharged FN 
patients with profound neutropenia were those five patients (3.3%) who were not given 
antibiotics in the ED. Although such stratification of patients’ risk is clinically revealing, 
it does not appear to have been used in making the clinical decision to discharge these 
patients.  
Many researchers and clinicians oppose the outpatient management of low-risk 
FN, considering it unsafe especially with its reduced sensitivity and specificity (Paddock 
et al., 2017; Taplitz et al., 2018). The rationale behind this opposition is that a high 
number of adverse events were documented when low-risk patients were treated as 
outpatients. Evidence indicates that one-third of ED patients who were identified as low-
risk by MASCC scores were found to have severe complications after discharge (Coyne 
et al., 2017; Paddock et al., 2017). Other organizations continue to allow outpatient 
management, but clear conditions are applied (Nova Scotia Oncological Emergencies 
Guidelines, 2014). The Nova Scotia Guidelines recommend that patients receive 
empirical antibacterial therapy within one hour of triage and be monitored for four hours 
before being discharged. Patients who do not get well after two to three days should be 
re-evaluated and considered for inpatient treatment. Patients with acute leukemia are 
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never regarded as a low-risk. In addition, individuals in Nova Scotia who are managed as 
outpatients must have prescription coverage, reside within 60 minutes of the ED, have 
telephone access, and have 24-hour live-in support. They should also be able to return to 
the facility for follow-up (Cancer Care Nova Scotia, 2014).  
The Effectiveness of Care 
Two measures were used to evaluate the effectiveness of care. At the primary level, 
the risk of FN can be minimized with the use of strategies such as growth factors and 
prophylactic antibiotics (Freifeld et al., 2011; Ganti et al., 2017; Smith et al., 2006; 
Taplitz et al., 2018). However, only 6.0% of patients in our sample had received 
Filgrastim (G-CSF) before their ED presentation. However, 29% (n = 123) of patients in 
our sample presented with profound neutropenia (ANC < 500). Szwajcer et al. (2011) 
reported similar underuse of G-CSF among patients with FN in which Filgrastim was 
administered to only 62.0% before their ED presentation. In the French study of critically 
ill cancer patients with FN, the authors reported that management was inadequate where 
G-CSF was initiated in the ED for only 10.0% of the patients (Andre et al., 2010). None 
of the patients in our sample started G-CSF in the ED. The second effectiveness indicator 
was the fractile response rate (FRR), which provided information about patient flow as it 
measures the adequacy of triage implementation suggesting ineffective triage 
implementation in 89% of the patients with FN. The guidelines mandate organizations to 
tailor different resources to meet this quality indicator because FRR is based on the 
urgency and acuity of the presenting complaint and is related to patient outcomes (Bullard 
et al., 2017). 
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Patient Centeredness  
Patient-centeredness was evaluated in terms of proper pain assessment and 
management. Berwick (2014) defined patient-centeredness as having three aspects: 1) the 
needs of the patient have priority, 2) the patient participates in all health decisions, 3) the 
patient receives the full attention of the health care team. The lack of appropriate pain 
assessment and management may mean that the patient needs were not given priority. The 
evaluation of pain was documented in only four patients (1.0%), while 38 patients (9.0%) 
presented with pain manifestations and 39 patients (9.0%) were found to receive opioids 
such as morphine. This finding is congruent with the data from previous studies reporting 
that some cancer patients do not receive proper pain management in the ED (Barbera et 
al., 2012; Jain et al., 2013; Patel et al., 2017). Furthermore, pain in cancer patients is often 
not an isolated symptom but a manifestation of severe underlying conditions such as 
compressed spinal cord, obstructed intestine, or compressed heart (Sun & Nemecek, 
2010). Cancer related pain can also be associated with other oncological emergencies 
including FN. It is the most common presenting symptom for patients with newly 
diagnosed cancer in the ED (Kehoe, 2007), as well as those who are living with the 
disease (Scholer et al., 2017). Pain can be unbearable symptom and can cause severe 
suffering and inferior quality of life (Jain et al., 2013). It is also a forerunner of urgency 
as it is the chief complaint among patients who get admitted from the ED (Barbera et al., 
2010). The lack of formal pain assessment may indicate a lack of awareness. Pain should 
be managed, even at the triage stage, with the suitable analgesia until the patient can go 
through the proper examination to identify the underlying cause of pain. Education of the 
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triage nurses with the introduction of an advanced protocol for analgesic treatment can 
improve their quality of care and minimize patient suffering (Jain et al., 2013).  
The Timeliness of Care 
Patients in our sample were not seen promptly, nor did they receive timely 
treatment in different phases of their ED visit. The average time to see a physician was 81 
minutes (95% CI [74, 88]) which was significantly longer than recommended for patients 
with FN (the expected PIA = 15 minutes). The average time to receive antibiotics was 
228 (95% CI [207, 248]) minutes which was significantly longer than that recommended 
for patients with FN (the expected TTA = 60 minutes). Our results were consistent with 
previous studies where ED wait times of cancer patients with FN were far from ideal 
benchmarks. Patients were found to experience at least between 180 and 300 minutes 
before the administration of antibiotics (Nirenberg et al., 2004; Oatley et al., 2015; 
Szwajcer et al., 2011). 
Untimely care was also demonstrated by the long period of time that study 
participants spent in the ED waiting to receive necessary services. In Canada and the UK, 
the expected benchmark for ED length of stay (ED LOS) for patients who are discharged 
is four hours. For individuals who require inpatient admission, the ED LOS benchmark is 
eight hours (Health Quality Ontario, 2016; Iacobucci, 2019). Patients in our study 
experienced longer ED stays than recommended. Discharged patients spent an average of 
four and a half hours in the ED while admitted patients were in the ED for an average of 
22 hours.  
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Implications and Limitations 
Quality is about changing the behavior of health care providers by using evidence 
to drive their decisions (Berwick, 2014). This review of quality indicators in the ED 
revealed that aspects of the care provided for this sample of patients with FN was not 
based on evidence nor was consistent with the guidelines. There was a considerable gap 
in the care proposed by the guidelines and the actual care that was received by patients in 
the ED. Quality initiatives are needed to improve care to be safer, more effective, patient-
centered, and timely (IOM, 2003). However, this study was academic-led and focused on 
a specific patient population with a particular clinical condition (FN). This approach to 
quality improvement cannot be sustainable and could contribute to fragmented ED quality 
measurement and improvement. It is also time-consuming and can be challenging for 
most conditions because the conventional treatment, timeliness of the intervention, and 
prognosis can vary significantly among different conditions and across different illnesses. 
Hospitals need to establish ways to inspect quality in a way that is faster, easier, and cost 
effective. Investment could be made in health care information technology and health 
databases which turn data into information and then into knowledge that the caregivers 
can use to both deliver and improve care (Kelly et al., 2014). This will make the health 
workers aware of their performance and continuously improve the quality of the delivered 
care. Nurses who are in direct contact with the patients and who are actively involved in 
every single process of the health care system are well positioned to lead this change. 
Conclusion 
In evaluating the quality of emergency care of patients with FN, the results of this 
study provide evidence that additional improvements in a number of the quality 
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dimensions have potential to greatly enhance the care provided to individuals with FN. 
Strengthening the effectiveness of the care delivered to patients with FN will reduce the 
gap between the recommended evidence-based care and actual care.  
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The Impact of Emergency Department Triage on the Treatment Outcomes of Cancer 
Patients with Febrile Neutropenia 
 
 
Chapter Four 
 
 
This chapter constitutes the third manuscript of the thesis. The purpose was to evaluate 
whether patients with cancer received the appropriate triage score when they presented 
with FN, and to explore how inappropriate scores (mal-triage) affected the treatment 
process and treatment outcomes throughout the ED stay. Data were collected from the 
health records of all adults with cancer who presented with FN to one Canadian ED over 
a five-year period. 
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Abstract 
Background: The emergency department (ED) is an important entry point for patients 
with cancer requiring acute care due to oncological emergencies. Febrile neutropenia 
(FN) is one of the most common oncological emergencies and carries a significant risk of 
morbidity and mortality. There is evidence from previous studies that FN patients wait far 
longer in the ED than recommended by the triage and FN guidelines. 
Purpose: The aim was to examine whether individuals with cancer presenting at the ED 
with FN were triaged appropriately, and to explore if, and how, triage affected their 
treatment outcomes. 
Methods: A retrospective cohort design was employed to collect data over five years from 
all available ED records of adult cancer patients who presented with fever.  
Results: Of the 431 eligible patients, 63% (n = 272) were assigned triage scores that were 
detrimental to their immediate health. Findings from the multiple linear regression 
analyses showed that inaccurate or mal-triage was significantly associated with delayed 
times for the initial physician assessment, administration of antibiotics, and decision on 
admission. The absence of fever at the time of triage assessment contributed significantly 
to the prediction of mal-triage.  
Conclusion: The allocation of patients with FN to a lower, inaccurate priority was partly 
responsible for the inability of those patients to meet the standard benchmarks for the 
initial physician assessment and the administration of antibiotics identified by the triage 
and febrile neutropenia guidelines. Ongoing strategies are needed to both enhance the 
application of the triage guidelines and institute organizational and system changes that 
promote timeliness and effectiveness throughout the entire ED episode of care. 
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Febrile neutropenia (FN) is the most common oncological emergency (Bryant et 
al., 2015; Vandyk, Harrison, Macartney, Ross-White, & Stacey, 2012). FN results in 
considerable morbidity, mortality and costs, and can cause the termination of effective 
chemotherapy treatment (Lyman, Abella, & Pettengell, 2014). One study documented the 
clinical burden of FN as 13 days of hospital stay, 14.0% mortality, and a single 
hospitalization cost of over $22,000 (Kuderer et al., 2006). FN is considered potentially 
life-threatening as failure to implement immediate treatment can be associated with rapid 
progression to septicemia. Empiric antibiotic therapy should be initiated promptly as 
delayed initiation of antibiotics can relate to increased mortality (Adelberg & Bishop, 
2009; Gabriel, 2012; Livingston, Craike, & Slavin, 2012). Morneau and colleagues 
(2017) reported a 16.0% probability increase for in-hospital mortality for every hour of 
delay in the administration of the needed antibiotics, whereas other researchers have 
reported that early antibiotic administration is associated with fewer complications and 
higher survival rates among patients with FN (Lynn, Chen, Weng, & Chiu, 2013; Rosa & 
Goldani, 2014). The results from a recent systematic review provided strong evidence for 
early management in the ED suggesting a significant 33% reduction in mortality odds for 
immediate (within 1 hour) antibiotic administration (Johnston et al., 2017). Despite such 
benefits of early administration of antibiotics, delayed emergency care and prolonged 
time to antibiotics have been identified in many epidemiological studies (Nirenberg, 
Mulhearn, Lin, & Larson, 2004; Oatley, Fry, & Mullen, 2016; Szwajcer, Czaykowski, 
and Turner, 2011). 
In the ED, the demand for emergency service is unpredictable, and crowding 
within an ED is considered an inevitable event (Forero, Mccarthy, & Hillman, 2011). 
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However, timely and effective ED care is needed for good patient outcomes (Pines & 
Hollander, 2008). To better achieve this objective, many EDs established mechanisms to 
sort and prioritize patients to make sure that those with a life-threatening condition such 
as FN are seen immediately, while others with more stable conditions are safe to wait 
(Bullard et al., 2017). Historically, EDs did not use standardized triage systems, but since 
1999, scales have been introduced to Canadian EDs to standardize triage decisions 
making them more objective and justified (Beveridge et al., 1998; Murray, Bullard, & 
Grafstein, 2004). The Canadian Triage and Acuity Scale (CTAS) guidelines categorize 
ED arrival acuity into one of five numeric levels based on how urgently, in terms of 
minutes, patients need to be seen by the ED physician (Beveridge et al., 1998).  
Currently, cancer patients presenting with FN are benchmarked to be assessed 
within 15 minutes, which equates to a CTAS level of ‘2’ (Bullard et al., 2017). 
Antibiotics are to be given within one hour of the patient’s ED presentation (Freifeld et 
al., 2011). However, patients can be inappropriately triaged resulting in a longer wait time 
than is considered safe for their condition. Registered nurses are the professionals who 
carry out the triage function in most EDs. They are essential to initiating an effective 
treatment process for each patient. Assigning accurate triage scores is particularly crucial 
for patients with life-threatening conditions to ensure appropriate emergency care is 
provided promptly.              
This study represents a first step in meeting a longer-term goal of helping triage 
nurses bridge the gap between theory (the expected care), and practice (the observed or 
actual care). It was part of a more extensive study that examined the quality of ED care 
throughout the ED visit for cancer patients with FN. This study focused on triage 
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decisions and aimed to evaluate whether cancer patients presenting with FN were triaged 
appropriately and how triage affected their treatment outcomes. The findings from this 
study will be used to improve the care provided in the ED, expand the knowledge base of 
emergency care, and inform clinicians, administrators, researchers, and policymakers 
about the performance of the triage system and its effectiveness in promoting patient 
outcomes. 
Research Questions 
1. What effect does the mal-triage of patients with FN have on meeting care standards 
(time for the physician initial assessment and time to antibiotics), the decision time to 
admit/discharge, length of stay (LOS), and ED disposition? 
2. Can contextual factors (arrival time, arrival day, mode of arrival, and ED crowding) 
and select patient characteristics (age, sex, and vital signs) predict the occurrence of 
mal-triage among patients with FN? 
Methods 
The study design was a retrospective cohort. Data were collected from all 
available records of adult patients diagnosed with cancer who presented with fever to one 
urban ED triage in Atlantic Canada. Individuals were eligible if they were at least 18 
years of age and had presented to the ED with a fever in the five-year study period from 
2011 to 2016. Data were collected by conducting chart reviews using a standardized, 
piloted, chart review form (CRF). A pilot test of the CRF was performed, and changes 
were made as necessary to enhance the rigor and minimize biases. For example, the order 
of items on the CRF was changed to match the order of data in the patient health records. 
Each patient was assigned a unique de-identified study code to protect the confidentiality 
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of their information. Health ethics approval was obtained by the provincial health 
research ethics board (Ref #: 20190499). 
Cohort Assembly  
Identification of relevant health records required data linkages between the 
provincial cancer registry and ED electronic patient health records. The Cancer Registry 
for the province where this study was performed identified all adults who received a 
cancer diagnosis between 2011/12 and 2015/16. This list of individuals was sent by the 
Cancer Registry to a provincial health information agency where the data linkage was 
conducted. The health information agency identified all target patients from the Cancer 
Registry using the following inclusion criteria: i) diagnosed with cancer, ii) 18 years and 
older, iii) presented with fever to the ED during the study period, iv) the date of ED 
presentation was later than the date of cancer diagnosis, and v) only the first ED visit was 
included. All data transfer occurred securely through the Managed File Transfer (MFT) 
system.  
Eligible patients were categorized into two groups based on their exposure status. 
For this study, exposure was defined as receiving an inaccurate triage classification. The 
exposed group consisted of FN patients who were mal-triaged: that is, they received a 
CTAS score of ‘3’, ‘4’, or ‘5’. The unexposed group contained the individuals who were 
appropriately triaged: that is, were classified as ‘1’ or ‘2’ under the triage guidelines. 
Each participant in the sample was expected to receive a CTAS score of ‘2’ (or ‘1’ if 
he/she was unstable).  
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Measures 
The outcome variables of mal-triage represented different ED processes that were 
found to be essential determinants of the health outcomes for patients with FN (Bullard et 
al., 2017; Freifeld et al., 2011; Keng et al., 2015; Rosa & Goldani, 2014; Morneau et al., 
2017). These six variables were : i) time for the physician initial assessment (PIA), ii) 
time to antibiotics (TTA), iii) the decision time to admit or discharge, iv) ED disposition, 
v) ED length of stay (ED LOS), and vi) hospital length of stay (hospital LOS). 
Data were also collected about possible confounders that might have an impact on 
the study outcomes. In the regression models, we accounted for the following potential 
confounders: (1) patient demographics (age and sex), (2) vital signs (temperature (Temp), 
blood pressure (BP), heart rate (HR), respiratory rate (RR), and peripheral capillary 
oxygen saturation (spo2)), and (3) contextual factors (arrival mode, time of arrival, day of 
arrival, and ED crowding) (Atzema, Austin, Tu, & Schull, 2009). ED crowding was 
measured by boarding time which is the time spent in the ED after the decision was made 
to admit the patient (Hwang et al., 2011; Mccarthy et al., 2009). 
Furthermore, we applied additional scoring systems to assess the severity and the 
seriousness of FN in terms of i) growth factor use, ii) absolute neutrophil count (ANC), 
and iii) the Multinational Association for Supportive Care in Cancer scoring system 
(MASCC). Prophylactic administration of growth factors can be associated with a lower 
incidence or less severe FN and an improved recovery (Kawatkar et al., 2017). The ANC 
measures the percentage of neutrophils in the white blood count calculated by multiplying 
the white blood count (WBC) by the total neutrophils (segmented neutrophils% + 
segmented bands%) by ten. The ANC is indicative of immunosuppression and the risk for 
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infection. The MASCC is used to assess the seriousness of FN based on eight criteria that 
categorize the severity of FN into low and high-risk FN. These criteria were age of the 
patient, the burden of FN, presence of hypotension, having chronic obstructive pulmonary 
disease, solid tumor or hematologic malignancy, history of previous fungal infection, no 
dehydration requiring parenteral fluids, and the outpatient status (Taplitz et al., 2018). 
Quality Control  
We implemented a number of quality control audits to ensure the reliability and 
validity of data collection and entry. First, data were collected using a standardized form. 
Data collection was done by the first author of this article who had expertise in chart 
audits. The data were coded on a data entry form using a standardized codebook. Then, 
data entry was verified by the same researcher selecting a random sample of 176 cases 
(40% of our sample) for review to ensure correct data entry. Any variable with a single 
error in data entry was to be subjected to the full analysis of every case, to provide proper 
data entry for that variable. However, no errors were found in the predictor variable 
(triage score) or the main outcomes variables (PIA, TTA, and sorting time). 
Statistical Analysis  
The continuous variables (e.g., PIA, TTA, LOS, etc.) were summarized using 
means and standard deviations (SD) and were collapsed into categories according to the 
clinically substantial cut-offs. The categorical variables (e.g., sex, type of cancer, risk of 
FN, and ED disposition) were summarized using frequencies and percentages. The 
differences in the distribution between the exposed and unexposed groups were examined 
at baseline using the Chi-square test. The differences in the distributions between the two 
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groups were not statistically significant if the p-values were equal to or higher than the 
predetermined α level of 0.05.  
Multiple linear regression analyses were used to test if mal-triage was 
significantly associated with each of outcome variables while accounting for age, sex, 
time of arrival, mode of arrival, day of arrival, MASCC score, and ED crowding. 
Multiple logistic regression analyses were used to identify the factors which were 
significantly associated with risk of not meeting the guidelines’ time objective for 
physician initial assessment and antibiotic administration. Multiple logistic regression 
analysis was also used to identify the variables that were significantly associated with the 
occurrence of mal-triage. Also, bidirectional (backward & forward) elimination criteria 
for stepwise regression were implemented to build each of the multiple, different, final 
regression models with α entry of 0.20 and α stay of 0.05 after assessing any significant 
confounders and interaction effect. The analysis was done using the SAS software 
(version 9.4; SAS Institute Inc., Cary, NC, USA). 
Results 
Baseline Study Cohort Characteristics 
The study sample consisted of 431 patients who were categorized into one of two 
groups based on their exposure status. Two hundred and seventy-two patients (63%) from 
the total sample comprised the exposed or mal-triaged group. The exposed group received 
a triage score of ‘3’, ‘4’, or ‘5’. This group was 48% female and had an average age of 61 
years. The majority (n = 152, 56%) visited the ED during evening hours (15:00h to 
22:59h), and 14% (n = 37) arrived by ambulance. Nearly 69% (n = 188) were diagnosed 
with a solid cancer tumor, and the remaining 84 individuals (31%) had a form of 
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hematological cancer. Two-thirds (66%) of the mal-triage group were in an advanced 
stage of illness. 
The unexposed group, that is, those who received the appropriate triage score of 
‘1’ or ‘2’, constituted 37% (n = 159) of the total sample. This group was 50% female and 
slightly younger with an average age of 59 years. Over half of the unexposed group 
(55%) presented to the ED during evening hours (15:00h to 22:59h), and 13% arrived by 
ambulance. Two-thirds (n = 105) had a solid tumor, and one-third (n = 54) suffered from 
one of the hematological malignancies with more than half (57%) having advanced stage 
cancer. Table 1 provides the comparisons of the characteristics between the exposed and 
unexposed groups. The two groups were equivalent at the outset as there were no 
statistically significant differences regarding age, sex, type of malignancy, and stage of 
cancer, arrival time, day of arrival, mode of arrival, and prior growth factors 
administration (p > .05). The severity and the seriousness of FN are reported in Table 2. 
Around two-thirds of patients who were exposed (68%) and those who were unexposed 
(70%) were identified to have a high-risk FN (MASCC < 21). 36% of unexposed patients 
had profound neutropenia (ANC < 500) compared to 24% of patients who were exposed.  
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Table 1 
Description of the Study Cohort 
 
 
Characteristic 
 
 
Mal-triaged 
         Yes                       No 
        n (%)                   n (%) 
 
Sex 
 
Female 
 
130 (48) 
 
79 (50) 
 
Male 
 
142 (52) 
 
80 (50) 
Age <60 yrs. 100 (37) 74 (46) 
60-70 yrs. 106 (39) 52 (33) 
>70 yrs. 66 (24) 33 (21) 
Arrival Time 0700H-14:59H 69 (25) 41 (26) 
1500H-22:59H 152 (56) 88 (55) 
2300H-06:59H 51 (19) 30 (19) 
Day of Arrival Weekdays 189 (69) 104 (65) 
Weekends 83 (31) 55 (35) 
Arrival Mode Walk-In 235 (86) 139 (87) 
Ambulance 37 (14) 20 (13) 
Type of Malignancy Solid 188 (69) 105 (66) 
 Hematological 84 (31) 54 (34) 
Stage of Cancer 1+2 69 (34) 52 (43) 
3 63 (31) 36 (29) 
4 70 (35) 34 (28) 
Growth Factor G–CSF 12 (4.4) 14 (8.8) 
 None 260 (95.6) 145 (91.2) 
Note. The results from chi-square test revealed that the two groups were equivalent at the outset (p 
> .05). 
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Effect of Mal-triage on Treatment Outcomes 
Table 3 shows the effect of mal-triage on the treatment outcomes. The results 
from multiple linear regression analysis revealed that the mal-triage of patients with FN 
significantly prolonged the time for physician initial assessment (PIA). On average, mal-
triage was associated with 49 minutes increase (95% CI [36, 62], p = .001) before being 
seen by the ED physician. The multiple logistic regression analysis identified that patients 
who were mal-triaged were seven times more likely not to meet the benchmark time to be 
seen by a physician (within 15 minutes) compared to those who were appropriately 
triaged (OR = 7, 95% CI [2.6, 20.1], p = .001).  
 
Table 2 
Assessment and Risk Stratification of the Study Cohort 
 
Characteristic 
 
                     Mal-triaged 
          Yes                               No 
         n (%)                           n (%) 
Triage Score   
Resuscitation (1) - 1 (0.6) 
Emergent (2) - 158 (99.4) 
Urgent (3) 258 (95) - 
Less-Urgent (4) 13 (4.7) - 
None-Urgent (5) 1 (0.3) - 
Absolute Neutrophil Count   
ANC < 100 36 (13.2) 39 (24.5) 
100 < ANC < 500 29 (10.6) 19 (11.9) 
ANC >500 207 (76.2) 101 (63.6) 
Multinational Association for Supportive Care 
in Cancer 
 
 
 
 
High-Risk FN (MASCC < 21) 184 (67.6) 112 (70.4) 
Low-Risk FN (MASCC ≥ 21) 88 (32.4) 47 (29.6) 
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Table 3  
Comparison of Key Treatment Outcomes by Exposure Status (Multivariate Analyses) 
 
Outcome 
        
Mal-triaged 
 
Group Differences (β) 
 [95% CI] 
 p value 
        Yes        No  
Mean (SD)        Mean (SD)   
Physician Initial Assessment 
(PIA) (Minutes) 
99.0 (78.0) 50.0 (35.0) β = 49 
 [36, 62] 
 p = .001 
Time to Antibiotics (TTA) 
(Minutes) 
270.0 (216.6) 165.0 (114.2) β = 68 
 [27, 109] 
 p = .001 
Time to Decision for 
Admitted Patients (Hours) 
6.3 (3.2) 5.5 (3.5) β = 0.84 
 [0 .04, 1.70] 
 p = .045 
ED LOS (Hours) 21.0 (14.6) 22.0 (15.9) β = 0.49 
 [-0.33, 1.32] 
 p = .245 
Hospital LOS (Days) 7.6 (7.1) 8.2 (10.4) β = -0.49 
 [-2.59, 1.62] 
 p = .654 
Note. Variables included in the multivariate analysis were mal-triage, age, sex, time of arrival, mode of 
arrival, day of arrival, ANC, MASCC score, and ED crowding (boarding time). 
------------------------------------------ 
Final Model: PIA = mal-triage, sex, MASCC, & boarding time. 
Final Model: TTA = mal-triage, PIA, & boarding time.  
Final Model: Time to Decision on Admission = mal-triage, PIA, MASCC, & boarding time. 
Final Model: ED LOS = Time to Decision on Admission & boarding time. 
Final Model: Hospital LOS = boarding time. 
------------------------------------------------ 
Note. ANC = absolute neutrophil count; MASCC = Multinational Association for Supportive Care in 
Cancer scoring system. 
 
The results from multiple linear regression analysis have also shown that mal-
triage was significantly associated with delayed time to antibiotics (TTA). On average, 
mal-triage was associated with a delay of 68 minutes (95% CI [27, 109], p = .001) before 
the administration of antibiotic therapy. The multiple logistic regression analysis revealed 
that patients who were mal-triaged were over nine times more likely to fail to meet the 
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60-minute benchmark time for treatment compared to those who were appropriately 
triaged (OR = 9, 95% CI [2.1, 43.1], p = .003).  
In the multiple linear regression analysis, mal-triage was significantly associated 
with a prolonged time for an admission decision among the patients who were admitted 
from the ED (β = 0.84, t (272) = 2.1, p = .045). Mal-triage had no statistically significant 
impact on the ED length of stay (LOS) (p = .276). The average ED LOS was 21 and 22 
hours among mal-triaged patients and those who were appropriately triaged, respectively. 
For both groups, more than two-thirds of the ED LOS was spent waiting for an inpatient 
bed (Mean = 16 hours). Mal-triage had no statistically significant impact on hospital LOS 
with a mean hospital LOS of eight days (p = .654).  
Furthermore, despite the fact that a larger proportion of appropriately triaged 
patients were admitted compared to patients who were mal-triaged (70% vs. 60%), there 
were no significant differences in the disposition outcomes of the two groups (Table 4). 
The majority of patients from both the mal-triaged (n = 162) and appropriately triaged (n 
= 111) groups were admitted to an inpatient bed with a small number (14%) requiring 
admission to the ICU.  
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Table 4 
Disposition of the FN patients by Exposure Status in the ED 
 
 
 
 
Outcome 
 
Mal-triaged 
 
 
 
 
      Yes 
  
        No 
  
 
p value n (%) n (%)  
 
ED Disposition 
 
 
Admitted 
 
162 (60) 
 
111 (70) 
 
p = 0.055 
  
Discharged 
 
107 (40) 
 
48 (30) 
 
Admission Site 
 
 
ICU 
 
7 (4.3) 
 
11 (10) 
 
p = .178 
 
Ward 
 
154 (95.7) 
 
100 (90) 
 
Predictors of Mal-triage  
Multiple variables were examined to assess the occurrence of mal-triage. Only 
two variables were found to make a significant contribution to mal-triage. First, the 
absence of fever at the time of triage assessment contributed significantly to the 
prediction of mal-triage. Patients with a temperature of less than 38.0°C had double the 
risk of being mal-triaged compared to those whose measured temperature was more than 
38.0°C during the triage assessment (OR = 1.99, CI [1.26, 3.14], p = .003). Finally, heart 
rate (HR) contributed significantly to the prediction of mal-triage (OR = 0.97, CI [0.96, 
0.98], p = .001). Predictors of Mal-triage are shown in Table 5. 
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Table 5  
Predictors of Mal-triage 
Variable OR [95% CI], p value Variable OR [95% CI], p value 
Temp  
Afebrile vs. Febrile            
 
1.99 [1.26, 3.14], p = .003* 
HR 0.97 [0.96, 0.98], p = 
.001* 
Sex  
Males vs. Females             
 
0.92 [0.55, 1.54], p = .702 
spo2 0.96 [0.86, 1.07], p = 
.223 
 
Age   
 
0.99 [0.97, 1.01], p = .836 
BP 0.99 [0.97, 1.02], p = 
.672 
Arrival Time  
Evening vs. Day 
Night vs. Day    
 
 1.00 [0.54, 1.83], p = .999 
 1.01 [0.59, 1.73], p = .946 
RR 0.95 [0.86, 1.06], p = 
.134 
Day of Arrival 
Weekdays vs. Weekend             
  
0.58 [0.22, 1.34], p = .191 
MASCC Score 0.97 [0.90, 1.06], p = 
.813 
Mode of Arrival  
Walk-in vs. Ambulance            
 
1.15 [0.29, 4.56], p = .877 
ED Crowding 
Boarding time 
1.00 [1.00, 1.01], p = 
.283 
Type of 
Malignancy 
Solid vs. Hematological           
 
 
1.07 [0.53, 2.13], p = .632 
 
Growth Factors 
Yes vs. No             
 
0.77 [0.26, 2.29], p = 
.837 
    
Note. Variables included in the multivariate logistic regression analysis were age, sex, time of arrival, 
mode of arrival, day of arrival, MASCC score, vital signs, type of cancer, growth factor use, and ED 
crowding (boarding time). Only Temp and HR were remained in the final model; Temp = temperature; HR 
= heart rate; spo2 = peripheral capillary oxygen saturation; BP = blood pressure; RR = respiratory rate; 
MASCC = Multinational Association for Supportive Care in Cancer scoring system. 
 
Discussion 
The early recognition and the prompt delivery of emergency care of patients with 
FN have been recommended as effective strategies for several decades (Shelton, 1999). 
However, triage implementation can go wrong, exposing patients to mal-triage. We found 
that 63% of the patients in our sample were inappropriately triaged and assigned to less 
urgent triage categories. Our results are similar to previous studies that found assigned 
triages scores were not consistent with triage recommendations for patients with FN and 
conditions such as myocardial infarction (Atzema et al., 2009; Howlett & Atkinson, 2012; 
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Oatley et al., 2016; Szwajcer et al., 2011). The impact of mal-triage can be detrimental as 
inappropriate triage can translate into longer wait times and delayed treatment (Bryant et 
al., 2015; Mofid, Novin, Roointan, & Forouzanfar, 2016). 
The mal-triage of patients with FN was significantly associated with a number of 
clinically relevant treatment outcomes. On average, mal-triaged patients had to wait 99 
minutes (Median = 78 minutes) before being examined by the ED physician. The CTAS 
guidelines recommend a wait time no longer than 15 minutes for patients with FN. 
However, 98% of the patients who were mal-triaged were not seen by the physician 
within the expected timeframe. Patients who were mal-triaged were seven times more 
likely not to meet the benchmarked time to be seen by a physician compared to those who 
were appropriately triaged. Livingston and colleagues (2012) reported shorter wait time 
with the median ED wait time of 10 minutes. Strojnik et al. (2016) reported similar time 
to our study where patients had to wait for a median time of 75 minutes before being 
evaluated by the ED physician. 
Mal-triage was also significantly associated with prolonged TTA. On average, 
mal-triaged patients had to wait 270 minutes (Median = 197 minutes) before receiving the 
required antibiotics. The FN guidelines recommend the administration of antibiotics 
within one hour. Patients who were mal-triaged were over nine times more likely to fail to 
meet the 60-minute benchmark compared to those who were appropriately triaged. 
Courtney et al. (2007) reported that antibiotics were administered in the ED at a median 
time of 102 minutes. Lim et al. (2011) documented a median time from ED presentation 
to the start of antibiotic therapy of 120 minutes. Other studies reported longer median 
times of around 210 minutes (Burry et al., 2012; Nirenberg et al., 2004; Szwajcer et al., 
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2011). These results indicate that the ED assessment and care of FN patients does not 
reflect current guidelines regarding PIA and TTA, especially among those who were mal-
triaged.  
Our findings also revealed that mal-triage was significantly associated with a 
prolonged admission decision time. Moreover, while the evidence from multiple studies 
suggested that triage can be predictive of ED and hospital LOS, mal-triage had no 
statistically significant impact on ED LOS in this study. Boarding time was a better 
predictor of ED LOS than exposure to mal-triage. Boarding time measured the time from 
the decision to admit a patient to an inpatient service until the time the patient was 
transported to that service. The mean ED LOS in our sample was 16 hours with more than 
half of that time spent waiting for an inpatient bed (the mean boarding time = 10 hours). 
Only one study (Strojnik et al. 2016) reported a similar wait time (10 hours) from the 
admission decision until the final disposition to the inpatient unit. However, the ED LOS 
in our sample is much longer than what is reported in the literature. Nirenberg et al. 
(2004) reported a mean time for an ED LOS of 5.5 hours. Similarly, Oatley et al. (2016) 
documented a mean ED LOS for cancer patients of 8 hours compared to 5 hours for the 
entire ED presentations. Other studies reported shorter times with an ED LOS of 3.3 
hours (Courtney et al., 2007). This long ED LOS has the potential to affect the quality of 
care. Patients with FN are at a higher risk of infection and sepsis complications. 
Therefore, the standard of care is to keep those patients in protective isolation rather than 
leaving them in a highly infectious setting such as the ED setting (Freifeld et al., 2011; 
Vandyk et al., 2012). Finally, mal-triage had no statistically significant impact on hospital 
LOS. Boarding time was found a better predictor of hospital LOS than mal-triage. The 
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mean hospital LOS was eight days in both groups which is similar to the figures from 
previous studies (Culakova et al., 2004; Kawatkar et al., 2017; Oatley et al., 2016; 
Weycker et al., 2014).  
The absence of fever at the time of triage assessment contributed significantly to 
the prediction of mal-triage. Although fever is an essential sign of infection, lack of fever 
does not necessarily exclude it (Adelberg & Bishop, 2009). The FN clinical guidelines 
recommend that afebrile, neutropenic patients who have new signs or symptoms 
suggestive of infection be evaluated and treated as high-risk patients (Freifeld et al., 
2011). Patients with afebrile neutropenia were found to have significantly higher 30-day 
in-hospital mortality rates when compared to patients with FN (Strojnik et al., 2016). 
Vital signs are considered essential first-order modifiers that need to be applied, 
and if done so appropriately, can be used to change the initial anticipated triage acuity 
level (Murray et al., 2004). Ignoring the vital signs of these patients contradicts the 
definition of fever in FN where fever is defined as “a single oral temperature 
measurement of 38.3°C or a temperature of 38.0°C sustained over a 1-h period” (Freifeld 
et al., 2011, p.3). Accordingly, many patients in our study had a fever of 38.3°C in the 
ambulance or at home, but again were mal-triaged because the measured temperature at 
triage was 38°C or less. Still, half of patients who had a high fever (> 38.3°C) at triage 
were also mal-triaged to lower triage categories. Nirenberg et al. (2004) found that the 
majority of FN patients experienced fever for a mean time of 21 hours before seeking 
emergency care. Moreover, more than one-third (37%) of patients in our sample had 
profound neutropenia (ANC < 500) in the initial ANC results suggesting the earlier onset 
of FN from home. Triage nurses should follow the triage guidelines and allocate those 
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afebrile patients to the urgent triage category (level 2) if they report the occurrence of 
fever before presentation to the ED (Bullard et al., 2017). Furthermore, while heart rate 
(HR) contributed significantly to the prediction of mal-triage, we do not see any clinical 
significance for this result (OR ≈ 1) because the indication for the sinus tachycardia 
probably resulted from the presenting complaint of fever (increased temperature). 
A first step to improve the ED care of patients with FN is to enhance triage 
nurse’s knowledge of FN to better inform triage decision-making. This process should be 
continuous and interactive using an audit and feedback system. Knowledge of FN, 
including its signs and symptoms, is fundamental to enable triage nurses to differentiate 
the risk and urgency of FN. Triage decisions should be evaluated periodically, and regular 
triage competency assessments should be conducted annually. Also, as part of the 
competency assessment, chart audits should be carried out to provide individual triage 
nurses with the findings specific to their performance. Customized strategies could then 
be put in place to address the explicit challenges of each individual triage nurse.  
Accumulated evidence supports the need to conduct routine system monitoring 
and benchmark analysis to meet the time objectives set by the guidelines to tailor 
different ED resources to meet these benchmarks (Bullard et al., 2017; Howlett & 
Atkinson, 2012). The CTAS developers, for example, recommended a continuous 
monitoring of the time objective set out by the guidelines (Bullard, Unger, Spence, & 
Grafstein, 2008). In this study, we were driven by this mandate to make sure that patients 
with FN are identified early to receive a timely treatment with antibiotics as per the 
recommendations of the FN guidelines. This study focused solely on treatment outcomes 
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such as PIA and TTA; however, future research should examine the occurrence of severe 
adverse health outcomes such as sepsis, septic shock, and death. 
Strengths of this study include anticipating possible threats to validity and 
addressing them effectively. Selection bias was reduced because the subjects were 
recruited by the provincial information center who independently identified eligible 
relevant health records. Moreover, the use of standardized and piloted chart review form 
maintained the consistency of data collection process and minimized information bias. 
Last, we assessed and controlled the effect of possible confounding variables. Still, this 
study has some inherent limitations demonstrated in the employed retrospective design 
where the validity of the results will be dependent upon the accuracy of the reviewed 
medical records. Also, this observational design shares the common limitations in that 
unknown confounders often muddy the observed effect. Finally, we were not able to 
enroll patients who had recent visits to ED because there was a two-year delay in entering 
new individuals with a cancer diagnosis in the cancer registry.  
Conclusion 
To allocate patients with FN to a lower, inaccurate priority resulted in a longer 
time for the initial physician assessment, for the administration of antibiotics, and to 
decide on admission in the crowded and potentially high risk for acquiring infection. Mal-
triage contributed significantly to those patients not reaching the standard benchmark for 
initial physician assessment and the administration of antibiotics as recommended by the 
triage and febrile neutropenia guidelines. The rapid identification of these patients and 
prompt initiation of treatment is essential for better patient outcomes. Triage nurses 
should use the triage guidelines effectively to enable these patients to meet the 
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benchmarks. An audit and feedback system for the implementation of triage should be 
established to enhance conformance with guidelines. 
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Despite transformative changes and improvements in health care (e.g., electronic 
medical records and self-management in chronic diseases), problems related to poor 
quality care continue to exist (Graham & Varghese, 2011). In health care, the supply is 
always driven by the demand, disregarding the impact of such supply on the quality and 
outcome of care (Berwick, 2013). An example of this failure can be seen in the 
emergency departments (EDs) with a high demand for services, ED overcrowding, and 
long wait times (Ontario Hospital Association, 2006). However, patients who seek 
emergency care are likely to require time-sensitive interventions in which such long wait 
times could have a detrimental effect (Bullard et al., 2017).  
The institution of ED triage is considered one of the innovations to the delivery of 
the current emergency services to regulate the flow and trajectory of patients’ care within 
the department (Forero, Mccarthy, & Hillman, 2011). Historically, EDs did not use 
standardized triage acuity rating systems, but many emergency agencies support the 
adoption of a five-level triage scale such as the Canadian Triage and Acuity Scale 
(CTAS). The CTAS guidelines categorize ED arrival acuity into one of five numeric 
levels based on how urgently patients need to be seen by the ED physician. For instance, 
the guidelines prioritize cancer patients who present with fever and recommend allocating 
them to the second (emergent) triage category. This assigned triage score translates into 
the patient being assessed by a nurse and a physician within 15 minutes of their arrival to 
the ED (Bullard et al., 2014).  
The CTAS guidelines prioritize fever occurring in cancer patients because this 
manifestation alone can indicate a severe underlying infection (Freifeld et al., 2011; 
Weycker et al., 2016). Bone marrow suppression is an expected side effect for many 
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chemotherapy regimens (Adelberg & Bishop, 2009). Infection due to neutropenia is 
associated with significant morbidity and mortality in patients receiving chemotherapy 
(Walji et al., 2008). Evidence indicates that patients with febrile neutropenia (FN) who 
were exposed to longer ED wait times had substantial antibiotic delays and developed 
complications of infections and sepsis (Keng et al., 2015; Klastersky, 2004). Results from 
recent research have raised concerns regarding the accuracy of the triage process, as 
evidenced by a disparity in health care provision and subsequent adverse outcomes, 
especially among cancer patients with FN (Oatley, Fry, & Mullen., 2016; Szwajcer, 
Czaykowski, & Turner., 2011). Therefore, the purpose of this study was to evaluate the 
effectiveness of the CTAS guidelines in improving the treatment outcomes of cancer 
patients with FN.  
The developers of the CTAS recommended continuous monitoring to verify that 
the time objective in the guidelines is met and to assess the consistency of the triage 
process and the compliance in following the guidelines (Bullard, Unger, Spence, & 
Grafstein, 2008). The literature is lacking studies that determine the appropriateness 
of the triage implementation and assess the effectiveness of triage in improving patient 
outcomes. In this summary of my thesis, I have five main objectives. I first review 
the CTAS guidelines to evaluate if they were identifying the urgency of patients with 
FN. Second, I discuss the impact of implementing triage in clinical practice. Third, I  
provide a comprehensive assessment of select ED quality of care indicators for patients 
with FN. Fourth, I discuss the benefits of early recognition of patients with FN in the ED, 
highlighting the other factors that contribute to the delayed emergency care even among 
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patients who were appropriately triaged. Finally, I provide several implications for the 
results of this study for future research, nursing education and practice. 
The Acuity of Febrile Neutropenia Using the CTAS Guidelines 
In this study, the CTAS guidelines were evaluated to determine their effectiveness 
in improving the outcomes of patients with FN. At the theoretical level, I reviewed the 
CTAS guidelines, their different revisions and updates, the manuals used in the training 
of triage nurses, and the desktop-supported Complaint Oriented Triage (COT). I 
conducted an analysis applying the COT in the triage of select oncological emergencies 
and examined if the acuity of these emergencies was appropriately identified by the 
guidelines. I found that the CTAS guidelines do anticipate the acuity and urgency of FN. 
In particular, in the ED setting where the study was conducted, the policy is to use the 
COT to support the triage decision-making process. The COT prioritizes patients who are 
immunocompromised with neutropenia (or suspected) and assigns them a triage score of 
‘2’ without the need for any further assessment. The guidelines define 
immunocompromised status as those with neutropenia (or suspected neutropenia), or on 
chemotherapy or immunosuppressive drugs including steroids (Bullard et al., 2017). 
The COT is an interactive computerized tool used in Canadian EDs to triage 
patients. The COT system instructs the triage nurse to assign a triage score of ‘2’ to all 
immunocompromised patients, whatever their presenting chief complaint if they were 
found to have a fever during the triage assessment. Complaints such as chest pain, 
hypertension, general weakness, leg swelling, facial trauma, sore throat, facial pain, and 
even anorexia were considered emergent and must be assigned an acuity score of ‘2’ if 
the patient has an increased temperature at triage. 
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The Impact of Triage Implementation in Patients with Febrile Neutropenia  
The results of triage decision-making in clinical practice were evaluated by 
reviewing the medical records of all cancer patients who presented with FN to one 
Canadian ED. Such a focus was justified given the current evidence that identified 
variations in the triage process, with subsequent long wait times. Precision and accuracy 
of triage have been an ongoing problem, even with the use of the CTAS guidelines. The 
findings of multiple studies provide evidence that patients can be assigned to a level of 
urgency incongruent with the CTAS recommendations resulting in longer wait times 
(Howlett and Atkinson, 2012; Nirenberg et al., 2004; Oatley et al., 2016; Szwajcer et al., 
2011). 
I retrospectively followed patients with cancer who presented with fever to one 
ED triage in the five years from 2011 to 2016. My purpose was to evaluate whether 
cancer patients received the appropriate triage score when they presented with FN and to 
explore how mal-triaged decisions affected their treatment outcomes. Limited information 
is available to determine if proper and timely emergency care is provided for this 
vulnerable population. Previous studies were limited to examining the benchmarked time 
for the administration of antibiotics. This study took a broader perspective to be inclusive 
of various dimensions of quality within the ED. This research study can inform the 
adoption of evidence-based policies to enhance the efficiency and effectiveness of ED 
processes for more positive patient outcomes.  
Our results were in line with previous studies, in that cancer patients presenting to 
the ED with FN did not meet the benchmarked times for treatment as specified in the 
Canadian Triage and FN guidelines. In the ED, the mean waiting time from triage to 
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physician initial assessment (PIA) was 81 minutes. On average, patients had to wait for 
228 minutes before the administration of antibiotics (TTA). Two-thirds of the patients in 
our sample (63%) were mal-triaged to less urgent triage categories of three, four and five. 
The mal-triage of patients with FN was significantly associated with several clinically 
relevant treatment outcomes. On average, mal-triage was associated with 49 minutes 
delay before the ED physician saw the patients. Patients who were mal-triaged were 
seven times more likely to not meet the CTAS guidelines’ benchmarked time to be seen 
by a physician compared to those who were appropriately triaged. Mal-triage was also 
significantly associated with prolonged TTA. On average, mal-triage was associated with 
68 minutes delay before the administration of required antibiotics. Patients who were 
mal-triaged were 9.5 times more likely to not meet the FN guidelines’ benchmarked time 
for the administration of antibiotics compared to those who were appropriately triaged. 
Multiple variables were examined that were thought to predict the occurrence of 
mal-triage. The absence of fever at the time of triage assessment contributed significantly 
to the prediction of mal-triage. Patients with FN who presented with a temperature of less 
than 38.0°C had double the risk of being mal-triaged compared to those with high fever 
(Temperature ≥ 38.0°C). Although fever is a sign of infection, lack of fever does not 
necessarily exclude it (Adelberg & Bishop, 2009). The FN clinical guidelines recommend 
that afebrile neutropenic patients who have new signs or symptoms suggestive of 
infection be evaluated and treated as high-risk patients (Freifeld et al. 2011). Patients with 
afebrile neutropenia were found to have significantly higher 30-day in-hospital mortality 
rates when compared to patients with FN (Strojnik et al., 2016). 
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Many patients in the study’s sample had an increased, recorded temperature at 
home or in the ambulance but were mal-triaged when their triage temperature was 37.9°C 
and not 38.0°C. However, this understanding contradicts the definition of fever in FN as 
fever is defined as “a single oral temperature measurement of more than 38.3°C or a 
temperature of more than 38.0°C sustained over a 1-h period” (Freifeld et al., 2011, p.3). 
Accordingly, many patients had a fever of more than 38.3°C in the ambulance but again 
were mal-triaged because the measured temperature at triage was less than 38°C. Still, 
half of the patients who had a high fever (> 38.3°C) at triage were also mal-triaged to 
lower triage categories. This result can be very detrimental as inappropriate triage can 
translate into longer wait times and delayed treatment for time-sensitive interventions 
such as TTA (Bryant et al., 2015; Mofid, Novin, Roointan, & Forouzanfar, 2016). 
The Quality of Care of Patients with Febrile Neutropenia 
While the interest to conduct this research was driven primarily by our interest in 
triage, we also performed a comprehensive assessment of select ED quality of care 
indicators for patients with FN. Such a focus was justified given that the current evidence 
identified variations in care and long wait times in the ED (Oatley et al., 2016; Szwajcer 
et al., 2011). 
The results of our quality evaluation provided evidence that additional 
improvements in a number of the quality dimensions have the potential to enhance the 
care provided to individuals with FN. We demonstrated quality issues in four of the six 
aspects of quality defined by the Institute of Medicine to include safety, effectiveness, 
equity, efficiency, patient-centeredness, and timeliness of care. We found three indicators 
of potentially unsafe care including i) the absence of reassessment while waiting at triage, 
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ii) patients who had left the ED without being seen (LWBS), and iii) inappropriate 
discharge from the ED. Patients in our sample experiencing long delays were not 
reassessed while waiting at the triage which contradicts the CTAS recommendation to 
reassess delayed patients every 15 minutes. Moreover, although the frequency of patients 
who LWBS was minimal (1.4%), these patients cannot afford not to receive emergency 
care, and this rate should be zero for the care of FN patients to be considered safe. 
Disposition of patients was also unsafe in which two-thirds of the one-third of patients 
who were discharged home were discharged without receiving antibiotics in the ED. Of 
note, were the 53 high-risk discharged patients (34%) who cannot be eligible for an 
outpatient management (Paddock et al., 2017). Also, around 5% of those high-risk 
discharged patients were found to suffer from a profound neutropenia with ANC of less 
than 500. Among the high-risk discharged FN patients with profound neutropenia were 
those five patients (3.3%) who were not given antibiotics in the ED. Although such 
stratification of patients’ risk is clinically revealing, it does not appear to have been used 
in making the clinical decision to discharge these patients.  
In terms of the quality domain effectiveness, there was a notable gap in the care 
recommended by the guidelines and the actual care that was received by the patient. First, 
at the primary health care level, there was underuse of growth factors which are known to 
be effective in decreasing the risk of FN (Freifeld et al., 2011; Ganti et al., 2017; Smith et 
al., 2006; Taplitz et al., 2018). Also, none of the patients in our sample started growth 
factors in the ED despite their benefits in improving recovery (Freifeld et al., 2011; Ganti 
et al., 2017). The second effectiveness indicator was the fractile response rate (FRR) of 
triage implementation suggesting ineffective triage implementation in 89% of the patients 
ED TRIAGE AND THE OUTCOMES OF PATIENTS WITH FN 
 
158 
with FN. The guidelines mandate organizations to tailor different resources to meet this 
quality indicator because FRR is based on the urgency and acuity of the presenting 
complaint and is related to patient outcomes (Bullard et al., 2017). 
Patient-centeredness was another aspect of poor-quality care as demonstrated in 
the deficient responsiveness to pain management in the ED for patients with FN. The lack 
of appropriate pain assessment and management can indicate that the patient quality of 
life and preferences were ignored. The evaluation of pain was documented in only four 
patients (1.0%), while 39 patients (9.0%) were found to receive opioids such as morphine. 
This finding is congruent with the data from previous studies reporting that some patients 
do not receive proper pain management in the ED (Barbera et al., 2012; Jain et al., 2013; 
Patel et al., 2017). Education of the triage nurses with the introduction of an advanced 
protocol for analgesic treatment can improve their quality of care and minimize patient 
suffering (Jain et al., 2013).  
Patients in our sample were not seen promptly, nor did they receive timely 
treatment in different phases of their ED visit. The average time to see a physician was 81 
minutes which was longer than that recommended for patients with FN (within 15 
minutes). The average time to receive antibiotics was 228 minutes which was longer than 
that recommended for patients with FN (within 60 minutes). Untimely care can be also 
demonstrated in the 90th percentile time to treatment, which is the maximum amount of 
time within which nine out of 10 patients were treated. In Canada and the UK, the 
expected benchmark ED LOS for the discharged patients is four hours and eight hours for 
patients who get admitted from the ED (Health Quality Ontario, 2016; Lipley, 2004). 
However, on average, patients in our sample had to spend around 5 and 22 hours in the 
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ED among the discharged and admitted patients, respectively. Also, 90% of those 
immunocompromised patients had to spend more than 32 hours in the ED, which is a 
highly infectious environment, with 70% of this time spent waiting (possibly in a 
corridor) until the inpatient bed became available. This certainly can contribute to the 
longer hospital LOS in which patients were hospitalized, on average, for eight days with 
some patients having an extended stay of more than two months.  
Identification of the limitations of the actual care provided could be used to 
initiate a quality improvement cycle for patients with FN. Strengthening the quality of the 
care delivered to patients with FN will close the gap between the recommended evidence-
based care and the actual care that is received by patients in the ED. 
Patients Who were Triaged Appropriately 
The rapid identification of patients with FN and prompt initiation of treatment is 
an effective strategy for better patient outcomes (Freifeld et al. 2011). This was the 
rationale behind the need to establish the CTAS guidelines to guide ED nurses in the 
correct identification of patients’ needs, and therefore, ensure appropriate emergency care 
is provided promptly (Beveridge et al., 1998). According to the CTAS guidelines, time 
objectives are designed to ensure interventions are delivered on time with subsequent 
improved patient outcomes (Bullard et al., 2017). For example, patients in our sample 
who were triaged appropriately were enabled to be seen by a physician and to receive the 
required antibiotics, on average, in about 49 minutes and 68 minutes quicker than those 
who were mal-triaged. Moreover, patients who were triaged appropriately had better odds 
to meet the benchmark compared to those who were mal-triaged.  
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While 37% of our patients were assigned with the appropriate triage category 
(CTAS score of ‘2’), the majority (90%) of patients were not seen within the guidelines’ 
benchmarked time for the treatment of patients with FN. It seems that mal-triage is not 
the core problem. It is a problem, but if it was resolved, the benchmarks would still be 
unmet, at least in our sample. Although, the validity of this conclusion is limited to our 
ED because we rely on a single center study and the use of descriptive (proportion of 
patients) rather than inferential statistics. Further research is needed to identify the other 
contributing factors that includes multiple ED settings with larger sample size for better 
generalizable data. 
On the other hand, some evidence in the literature can still support this 
conclusion. It is not logical to conceive that triage alone would be the only contextual 
factor within the ED setting. This was evident in our sample where the majority of 
patients were not seen within the guidelines’ benchmarked time for the treatment of 
patients with FN. Other factors within the ED system likely contributed to this delay even 
among patients who were triaged appropriately. For instance, the ED is a complex 
environment that can get congested because it has an open-door policy. Also, the ED staff 
do not have control of their exit doors because they are unable to transfer patients to a 
hospital unit if there are no available beds (Affleck, Parks, Drummond, Rowe, & Ovens, 
2013). In the ED, wait time is the manifestation of the patient flow and is related to the 
unregulated inflow of patients and the outflow to inpatient beds. Therefore, an increase of 
illness or injury in the surrounding population or the inability to discharge patients from 
inpatient beds can increase wait time in the ED (Health Quality Ontario). 
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From a broader perspective, the wait time problem is complex and requires time 
and resources in many levels of the health care system. This problem may have primary 
causes concentrated outside the ED itself; it is part of a system-wide problem with access 
to care and would require system-wide solutions (Grol et al., 2013). This system problem 
is manifested as inadequate access to care as evident in the 2004 CMA report, in which 
the long wait times for ED services is identified as one of Canadians’ top four areas of 
concern about their health care system (CMA, 2004). Such concern is understandable 
because the impact of long wait times extends beyond the simple inconvenience of 
spending hours waiting in an ED. Indeed, it prevents patients from efficiently flowing 
through the system, and as a result, can cause many negative consequences by blocking 
access to care (Schull, Vermeulen, Guttmann, & Stukel, 2015).  
An excellent example of genuine commitment to ED accessibility can be drawn 
from the United Kingdom where decreased ED wait time was observed following 
changes in all levels of the healthcare system (Cass, 2005). This success highlighted the 
need to develop integrated, system-wide solutions in response to the underlying problems 
driving ED wait times. The target was to decide the final disposition of ED patients 
within a four-hour time frame. This was coupled with an aggressive and comprehensive 
emergency care reform strategy and a government commitment to funding. A diagnostic 
tool was used to pinpoint the leading causes of delays in each ED and results were used to 
help health communities better understand where they needed to focus. Since the 
implementation of the strategy, 96% of patients were found spending four hours or less in 
UK EDs (Lipley, 2004). However, in recent years, the health board recorded the worst 
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performance with 79.3% of patients receiving ED care within the four-hour target 
(Iacobucci, 2019).  
Implications 
The study results have many implications for future research, nursing 
education, and practice. While the study was focused on examining the effect of mal-
triage on important treatment outcomes such as PIA and TTA, future research should 
examine the occurrence of severe adverse consequences such as sepsis, septic shock, and 
death because research relates these health outcomes to the treatment outcomes that were 
identified to be determined by the accuracy of the triage decision. Mortality was rare in 
this study (7%); a case-control study is recommended to study mortality and examine if 
patients who have died had higher exposure to mal-triage. Research is also needed to 
compare individuals with FN to individuals who have afebrile neutropenia to assess if the 
absence of fever at ED presentation can be associated with their allocation to inaccurate 
CTAS categories. It would also be useful to replicate this Canadian study using other 
patient populations seeking different types of emergency care. 
Furthermore, qualitative research is needed to explore the factors contributing to 
wrong triage decisions. This research could investigate the experiential knowledge of 
triage nurses but could also include the experiences of patients and families. For example, 
in this study, two participants were mal-triaged, had long wait times, and were discharged 
home. Both returned to the ED on the same day; one was admitted for an extended time 
(63 days), and the other participant did not survive to be discharged. The families of those 
patients could be interviewed to help understand the context of triage decisions.  
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The results of this study have many implications for nursing education and 
practice as well. Triage decision-making was problematic as triage decisions were 
incorrect for two-thirds of the patients in our sample. There is good evidence that nurses 
with proper knowledge are more accurate, and therefore, safer when making triage 
decisions (Considine, Botti, & Thomas, 2007; Martin et al., 2014). The reasons why there 
was mal-triaged remains unclear, but it does warrant further consideration and 
investigation. Our findings point to the need for a review of triage training and policies to 
increase their effectiveness. The implementation of annual triage competency assessments 
should also be considered. As a starting point, providing nurses with ongoing education 
and simulated practice to better understand the complexity of the needed care and 
expected outcomes with proper triage decisions are foundational to improving the quality 
of care in the ED (Grol et al., 2013). Education can make incremental changes to the 
triage process and can improve access to health care by increasing the triage nurse’s 
knowledge of the advantages and consequences of correct triage decisions. Triage nurses 
need to be well informed about the scientific evidence to strengthen their compliance with 
the guidelines (Grol et al., 2013). The manuscripts produced from this dissertation are one 
of the tools that can be used to guide nurses in achieving more accurate triage decisions. 
Continuing education efforts need to be directed toward both CTAS guidelines and the 
high-risk oncological emergencies that are initially managed in the ED (Howlett & 
Atkinson, 2012).  
Improvements in the treatment of cancer patients within the ED can be attained by 
implementing change to improve management of patients, not only to a limited place at 
triage. Instead, the change can consider the complexity of care and assure the continuity 
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of care at all parts of the system. At the individual level, education remains the 
cornerstone to prepare the triage nurses to deliver high-quality nursing care. At this basic 
level, education strategies should address the need to objectify the triage process and to 
promote compliance in using the guidelines. Assignment of triage level is expected to 
become more objective and less open to debate. This specific recommendation was made 
by the establishers of the CTAS guidelines, to properly use and implement the CTAS 
guidelines to make an accurate assignment of triage levels (Bullard, Unger, Spence, & 
Grafstein, 2008). With the different approaches that were used to improve the consistency 
and accuracy of triage, audit, and feedback can be the most effective strategy because this 
strategy will provide a continuous feedback system (Howlett & Atkinson. 2012). This 
monitoring and surveillance by the ED nursing leaders will make the triage nurses 
responsible and accountable to take ownership in improving their triage decisions and the 
emergency care they provide.  
At the organizational level, a change is needed in the process of ED care, or the 
redesign of the organizational structures that impact the inflow, treatment within, and 
outflow of patients in the ED. For instance, hospitals may need to adopt or to establish 
algorithms, protocols, or standardized order sets to lower the time to antibiotic 
administration among patients with FN (Baltic, Schlosser, & Bedell, 2002). The notion 
behind this is that specific hospital pathways may be designed for particular patients to 
improve their access and consequently their outcomes (Kennelly et al., 2014). However, 
this should be based on real and up-to-date information in which the health organizations 
conduct routine system monitoring and benchmarks analysis and then tailor different ED 
resources to meet these benchmarks. This approach is feasible in Canada across the 
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provinces as data is now readily available for hospital performance about ED triage, wait 
times, and length of stays (Health Council of Canada, 2012). This information system 
should be used by clinicians and researchers to continuously monitor the performance of 
ED triage and wait times against the benchmarks. With this system, successful EDs 
across Canada can share examples of optimal working methods from the other settings 
sharing the same problems. Also, the uniformity of using CTAS across Canada provides 
an opportunity to study triage and wait time among patients with different presentations 
and set a target for minimum benchmarking across the country (Atzema, Austin, Tu, & 
Schull, 2009). Still, a significant level of coordination and integration of care between 
hospital and alternative care settings is mandatory to deliver high-quality care in the 
safest, most effective, and efficient way, while reliving some of the pressure on the EDs 
(Health Quality Ontario, 2016). 
Conclusion 
The study of my dissertation provides essential information about many of the 
factors that contribute to the quality of ED care of cancer patients with FN, and 
potentially to other ED patients. The available evidence was focused primarily on the 
consistency of triage decisions and  neglected the primary objective of why triage was 
implemented; that is, the improvement of the patient outcomes. In this study, the 
application of triage to practice was evaluated, and the results showed a lack of 
consistency, lack of accuracy, and a significant impact on treatment outcomes that can 
result in adverse patient health outcomes. These results contribute to understanding the 
three factors that influence the mal-triage of patients with FN: inappropriate application 
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of the CTAS by triage nurses, inherent problems within the triage system itself, and the 
difficulty in recognizing FN patients. 
While the location of the main problems has been identified, the local health 
system decision-makers need to conduct a broader examination to understand better 
where they need to focus. These problems are expected to inflate with time as the 
pressure on emergency departments is likely to increase with the growth of an aging 
population. Therefore, any changes and improvements that do not anticipate the future are 
expected to become less effective soon. In particular, if these changes were an easy fix 
with a limited implementation to the emergency environment. Triage decisions have to 
improve and become highly objective. However, this is not going to improve the care in 
the ED as long as problems in other parts of the system remained unresolved and continue 
to impact the ED quality of care. 
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Appendix A 
Patient Chart Review Form (CRF) 
A. Patient Information 
1. Patient’s Deidentified Code............................           
2. Patient’s Age at Triage...............Day   Month   Year     
3. Patient’s Sex...................................................Male  Female  Other  
 
B. Triage 
1. Date of Triage.............................Day   Month   Year     
2. Time of Triage.....................................................Hour   Minutes   
3. Arrival Mode...............................Walking  Wheelchair  Ambulance  
4. Assigned Triage Score..................One  Two  Three  Four  Five   
5. Time to Reassessment..........................................Hour   Minutes   
6. Re-Triaged................................................No  Yes ; The new Score  
 
C. Clinical Presentation 
1. Presenting Complaint................................................................................  
 
2. Vital signs:  
i. BP..................................................................................................  
ii. HR. ................................................................................................  
iii. RR..................................................................................................  
iv. Spo2...............................................................................................  
v. Temperature...................................................................................  
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vi. Pain Score......................................................................................  
 
 
D. ED Treatment 
1. Left without Being Seen..........................................................No  Yes  
2. Time to Physician................................................Hour   Minutes   
3. Time to Analgesia................................................Hour   Minutes   
4. Type of Antibiotic..........Antibacterial ;Antiviral ; Antifungal agent  
None  
5. Time to Antibiotics..............................................Hour   Minutes   
6. Time to Decision in ED.......................................Hour   Minutes   
7.  Decision Taken............................Admission  Discharged  Referred  
8. Departure Time....................................................Hour   Minutes   
9. Final Disposition from ED.............Admission  Expired  Discharged  
10. Location of Admission if admitted............Tumor Centre  OR  ICU  
Ward  
11. Admission Diagnosis.................................................................................  
12. EDLOS.................................................................Hour   Minutes   
13. Boarding Time.....................................................Hour   Minutes   
14. HospLOS.............................................................Hour   Minutes   
 
E. Oncological Information: 
1. Type of Cancer........................................................................................  
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2. Stage of Disease........................................1 ; 2 ; 3 ; 4 ; NA  
3. Growth Factor...........None ; Granulocyte–Colony-Stimulating Factor  
 
F. Laboratory Value:  
1. White Blood Cell Count...............................................................X 109/L  
2. Polys.......................................................................................................%   
3. Bands......................................................................................................%  
4. ANC.......................................................................................................%  
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Appendix B 
Operational Definitions 
§ Leave without Being Seen (LWBS): is a patient with failed attempt to enter the health 
care system. They are ED patients who leave the ED on their own without proper 
discharge by the ED physician or nurse. 
§ Fractile Response Rate (FRR): is the proportions of patients in each triage level seen 
within the CTAS time objective for that level. The guidelines recommend FRR of 98, 
95, 90, 85, and 80 for the CTAS categories of I, II, III, IV, and V, respectively. 
§ Time to Reassessment for Each CTAS Category: is the time from initial assessment at 
triage to the secondary assessment at triage when the observed wait time has passed 
the expected wait time as benchmarked in the CTAS guidelines. This evaluation is 
part of the triage process and the triage nurses are expected per the CTAS guidelines 
to continuously assess patients in category 1, every 15 minutes for patients with level 
2, every 30 minutes for patients with level 3, every 60 minutes for patients with level 
4, and every 120 minutes for patients with CTAS score of 5. 
§ Mal-triaged: are those FN patients who were assigned to a lower acuity triage 
category (3,4, & 5). Also, the rate of Mal-triage will be calculated as the percentage of 
FN patients who are assigned to a lower triage category of III, IV, and V. 
§ Time to Physician: is the time spent in the ED from the door (ED triage assessment) 
to be seen by an ED physician (initial physician assessment). 
§ Time to Antibiotics: is the time spent in the ED from the door (ED triage assessment) 
to the administration of indicated antibiotics.  
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§ Boarding Time: is the time spent in the ED after the decision to admit until a hospital 
bed becomes available. 
§ Emergency Department Length of Stay (EDLOS): is the time (in hours and minutes) 
from the door (ED triage assessment) until the disposition to be admitted or 
discharged. 
§ Hospital Length of Stay (HospLOS): is the time of days from admission until 
discharge. 
§ Reassignment of CTAS Score (Re-Triage): is a patient who is initial triage score is 
changed for any given reason. 
§ Absolute Neutrophil Count: measures the percentage of neutrophils in the white blood 
count. The ANC is calculated by multiplying the white blood count (WBC) by the 
total neutrophils (segmented neutrophils% + segmented bands%) by 10. 
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Appendix C 
 Approval from Health Research Ethics Board (HREB) 
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Appendix D 
Approval from Newfoundland & Labrador Centre for Health Information (NLCHI) 
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